| SEC Info | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
| Database maintenance is being performed. If something doesn’t work, please try again shortly. |
As Of Filer Filing As/For/On Docs:Pgs Issuer Agent
10/17/03 Hudson Physical Therapy Svcs In S-4 20:803 Bowne of Philadelphia FA
Select Air II Inc
Select Management Services LLC
Select Rehabilitation Management Services Inc
Select Specialty Hospital Bloomington Inc
Select Specialty Hospital Boston Inc
Select Specialty Hospital Conroe Inc
Select Specialty Hospital Honolulu Inc
Select Specialty Hospital Lansing Inc
Select Specialty Hospital Lee Inc
Select Specialty Hospital Leon Inc
Select Specialty Hospital Lexington Inc
Select Specialty Hospital Macon Inc
Select Specialty Hospital Marion Inc
Select Specialty Hospital Orange Inc
Select Specialty Hospital Palm Beach Inc
Select Specialty Hospital Saginaw Inc
Select Specialty Hospital Sarasota Inc
Select Specialty Hospital Western Missouri Inc
Select Specialty Hospital Zanesville Inc
Select Transport Inc
South Philadelphia Occupational Health Inc
Victoria Healthcare Inc
Kessler Rehab of Connecticut Inc
Kessler Rehabilition of Maryland Inc
Kessler Rehabilitation of Florida Inc
Kessler Rehab Centers Inc
Kessler Rehabilitation Corp
Argosy Health LLC
Atra Services Inc
Community Rehab Centers of Massachusetts Inc
Core Rehab Management LLC
CRF Rehabilitation Associates Inc
Edgewater Rehabilitation Associates Inc
Horizon Health & Rehabilitation Inc
Kessler Assisted Living Corp
Kessler Care Center at Ceder Grove Inc
Kessler Institute for Rehabilitation Inc
Kessler Occupational Medicine Centers Inc
Kessler Physical Therapy & Rehabilitation Inc
Kessler Rehabilitation Services Inc
Pennsylvania Rehab Inc
Physical Therapy Associates Inc
Wilpage Inc
Select Specialty Hospital Escambia Inc
Kessler Care Center at Great Falls Inc
Kessler Care Center at St Cloud Inc
Intensiva Hospital of Greater St Louis Inc
Joyner Sports Science Institute Inc
Kentucky Rehabilitation Services Inc
Lynn M Carlson Inc
Metro Rehabilitation Services Inc
Michigan Therapy Centre Inc
Midatlantic Health Group Inc
Monmouth Rehabilitation Inc
New Mexico Physical Therapists Inc
Northside Physical Therapy Inc
Novacare Health Group LLC
Novacare Occupational Health Services Inc
Novacare Outpatient Rehabilitation Inc
Novacare Outpatient Rehabilitation East Inc
Novacare Outpatient Rehabilitation West Inc
Novacare Rehabilitation Inc
NW Rehabilitation Associates Inc
PT Services Co
PT Services Inc
PT Services Rehabilitation Inc
Peter Trailov Rpt Physical Therapy Clinic Orthopaedic
Physical Rehabilitation Partners Inc
Physical Therapy Enterprises Inc
Physical Therapy Institute Inc
Physical Therapy Services of the Jersey Cape Inc
Physio Associates Inc
Pro Active Therapy of Ahoskie Inc
Pro Active Therapy of Gaffney Inc
Pro Active Therapy of Greenville Inc
Pro Active Therapy of North Carolina Inc
Pro Active Therapy of South Carolina Inc
Pro Active Therapy of Virginia Inc
Pro Active Therapy of Rocky Mount Inc
Professional Therapeutic Services Inc
Quad City Management Inc
Rci Colorado Inc
Pro Active Therapy Inc
Rci Exertec Inc
Indianapolis Physical Therapy & Sports Medicine Inc
Rehabclinics Inc
Joyner Sportsmedicine Institute Inc
American Transitional Hospitals Inc
Intensiva Healthcare Corp
Select Medical Corp
Select Medical of Ohio Inc
Select Medical of Pennsylvania Inc
Affiliated Physical Therapists Ltd
Select Software Ventures LLC
Allegany Hearing & Speech Inc
Select Specialty Hospital Akron Inc
Select Medical Rehabilitation Clinics Inc
Select Specialty Hospital Ann Arbor Inc
Select Specialty Hospital Battle Creek Inc
Human Performance & Fitness Inc
Select Specialty Hospital Beech Grove Inc
Atlantic Rehabilitation Services Inc
Select Specialty Hospital Central Detroit Inc
Select Specialty Hospital Charleston Inc
Select Specialty Hospital Albuquerque Inc
Select Specialty Hospital Cincinnati Inc
Select Specialty Hospital Columbus Inc
Select Specialty Hospital Dallas Inc
Select Specialty Hospital Denver Inc
Select Specialty Hospital Durham Inc
Buendel Physical Therapy Inc
Select Specialty Hospital Erie Inc
Cer West Inc
Select Specialty Hospital Evansville Inc
Coast Institute Physical Therapy Inc
Select Specialty Hospital Flint Inc
Ccisub Inc
Rci Michigan Inc
Select Specialty Hospital Fort Smith Inc
Rci Sport Inc
Rci Wrs Inc
Cenla Physical Therapy & Rehabilitation Agency Inc
Select Specialty Hospital Gadsden Inc
Center for Evaluation & Rehabilitation Inc
Select Specialty Hospital Fort Wayne Inc
Select Specialty Hospital Greensburg Inc
Select Specialty Hospital Houston Inc
Rebound Oklahoma Inc
Select Specialty Hospital Indianapolis Inc
Redwood Pacific Therapies Inc
Select Specialty Hospital Jackson Inc
Select Specialty Hospital Johnstown Inc
Select Specialty Hospital Kansas City Inc
Select Specialty Hospital Knoxville Inc
Select Specialty Hospital Little Rock Inc
Select Specialty Hospital Louisville Inc
Select Specialty Hospital Macomb County Inc
Select Specialty Hospital Memphis Inc
Select Specialty Hospital Arizona Inc
Select Specialty Hospital South Dallas Inc
Select Specialty Hospital Milwaukee Inc
Select Specialty Hospital Morgantown Inc
Select Specialty Hospital Nashville Inc
Select Specialty Hospital New Orleans Inc
Select Specialty Hospital North Knoxville Inc
Rehab Advantage Inc
Select Specialty Hospital Northwest Detroit Inc
Rehab Managed Care of Arizona Inc
Rehab Provider Network-California Inc
Select Specialty Hospital Northwest Indiana Inc
Rehab Provider Network-East I Inc
Rehab Provider Network-Georgia Inc
Select Specialty Hospital Oklahoma City Inc
Rehab Provider Network-Indiana Inc
Rehab Provider Network-East II Inc
Rehab Provider Network-Michigan Inc
Rehab Provider Network-New Jersey Inc
Rehab Provider Network-Ohio Inc
Select Specialty Hospital Oklahoma City East Campus Inc
Rehab Provider Network-Oklahoma Inc
Rehab Provider Network-Pennsylvania Inc
Select Specialty Hospital Omaha Inc
Rehab Provider Network-Washington Dc Inc
Center for Physical Therapy & Sports Rehabilitation Inc
Rehab Provider Network of Colorado Inc
Select Specialty Hospital Philadelphia Aemc Inc
Select Specialty Hospital Phoenix Inc
Center Therapy Inc
Champion Physical Therapy Inc
Coplin Physical Therapy Associates Inc
Crowley Physical Therapy Clinic Inc
Rehab Provider Network of Florida Inc
Douglas Avery & Associates Ltd
Rehab Provider Network of Nevada Inc
Rehab Provider Network of New Mexico Inc
Rehab Provider Network of North Carolina Inc
Rehab Provider Network of Texas Inc
Elk County Physical Therapy Inc
Rehab Provider Network of Wisconsin Inc
Select Specialty Hospital Huntsville Inc
Rehab/Work Hardening Management Associates Ltd
Fine Bryant & Wah Inc
Francis Naselli Jr & Stewart Rich Physical Therapists Inc
Rehabclinics Galaxy Inc
Gallery Physical Therapy Center Inc
Rehabclinics Pta Inc
Georgia Physical Therapy Inc
GP Therapy LLC
Greater Sacramento Physical Therapy Associates Inc
Grove City Physical Therapy & Sports Medicine Inc
Gulf Breeze Physical Therapy Inc
Rehabclinics Spt Inc
Rehabclinics Abilene Inc
Hand Therapy Associates Inc
Rehabclinics Dallas Inc
Hand Therapy & Rehabilitation Associates Inc
Rehabclinics Pennsylvania Inc
Hangtown Physical Therapy Inc
Hawley Physical Therapy Inc
Start Inc
Select Employment Services Inc
Select Hospital Investors Inc
Selectmark Inc
Select Medical of Kentucky Inc
Select Medical of Maryland Inc
Select Medical of New Jersey Inc
Select Medical of New York Inc
New England Health Group Inc
Georgia Physical Therapy of West Georgia Inc/GA
Select Specialty Hospital Pittsburgh Inc
Select Specialty Hospital Pontiac Inc
Select Specialty Hospital Reno Inc
Select Specialty Hospital San Antonio Inc
Select Specialty Hospital Sioux Falls Inc
Select Specialty Hospital Topeka Inc
Select Specialty Hospital Tricities Inc
Select Specialty Hospital Tulsa Inc
Select Specialty Hospital Columbus Grant Inc
Select Specialty Hospital Western Michigan Inc
Select Specialty Hospital Wichita Inc
Select Specialty Hospital Wilmington Inc
Select Specialty Hospital Wyandotte Inc
Select Specialty Hospital Youngstown Inc
Select Specialty Hospital Inc
Select Synergos Inc
Select Unit Management Inc
SLMC Finance Corp
Select Provider Networks Inc
South Jersey Physical Therapy Associates Inc
South Jersey Rehabilitation & Sports Medicine Center Inc
Southpointe Fitness Center Inc
Southwest Emergency Associates Inc
Southwest Physical Therapy Inc
Southwest Therapists Inc
Sports & Orthopedic Rehalilitation Services Inc
Stephenson Holtz Inc
Center for Physical Therapy & Rehabilitation Inc
TJ Partnership I
Treister Inc
Novacare Outpatient Rehabilitation of California Inc
Valley Group Physical Therapists Inc
Vanguard Rehabilitation Inc
Wayzata Physical Therapy Center Inc
West Penn Rehabilitation Services Inc
West Side Physical Therapy Inc
West Suburban Health Partners Inc
Avalon Rehabilitation & Healthcare LLC
Select Specialty Hospital Columbus University Inc
Orthopedic Sports & Industrial Rehabilitation Network Inc
Yuma Rehabilitation Center Inc
Athens Sports Medicine Clinic Inc
Ather Sports Injury Clinic Inc
Atlantic Health Group Inc
Document/Exhibit Description Pages Size 1: S-4 Select Medical Corp. HTML 3,013K 2: EX-2.5 Agreement and Plan of Merger Dated 09/02/2004 3 72K 3: EX-4.4 Indenture Governing 7 1/2% Senior Sub. Notes 166 640K 4: EX-4.6 Exchange and Registration Rights Agreement 33 177K 5: EX-4.7 Supplemental Indenture Dated As of 09/02/2003 15 106K 6: EX-4.8 Assumption Agreement Dated As of 09/02/2003 14 101K 7: EX-10.74 Fifth Amendment Dated 07/29/2003 to Credit Agree. 38 127K 8: EX-10.75 Purchase Agreement Dated As of July 29, 2003 86 325K 9: EX-10.76 Escrow Agreement Dated As of August 12, 2003 18 130K 10: EX-12.1 Statement of Corporation of Ratio of Earnings 2± 73K 11: EX-21.1 Subsidiaries of Select Medical Corporation 8 95K 12: EX-23.1 Consent of Pricewaterhousecoopers Llp 1 67K 13: EX-23.2 Consent of Pricewaterhousecoopers Llp 1 67K 14: EX-25.1 Statement of Eligibility of Trustee 4 80K 15: EX-99.1 Form of Letter of Transmittal 13 121K 16: EX-99.2 Form of Notice of Guaranteed Delivery 4 79K 17: EX-99.3 Letter to Holder of 7 1/2% Senior Sub. Notes 1 67K 18: EX-99.4 Letter to Brokers, Dealers, Commercial Banks 2 73K 19: EX-99.5 Letter to Clients Concerning Offer 3 74K 20: EX-99.6 Guidelines for Certification of Taxpayer Ident. 2± 72K
|
| sv4 |
SECURITIES AND EXCHANGE COMMISSION
FORM S-4
Select Medical Corporation
| Delaware | 8093 | 23-2872718 | ||
|
(State or Other Jurisdiction of Incorporation or Organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification No.) |
4716 Old Gettysburg Road
See Table of Additional Registrants Below
Michael E. Tarvin, Esq.
With a Copy to:
Christopher G. Karras, Esq.
Approximate date of commencement of proposed sale of the securities to the public: As soon as practicable after this Registration Statement becomes effective.
If the securities being registered on this Form are being offered in connection with the formation of a holding company and there is compliance with General Instruction G, check the following box. o
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
CALCULATION OF REGISTRATION FEE
| Amount | Proposed Maximum | Proposed Maximum | Amount of | |||||
| Title of each Class of | to be | Offering Price | Aggregate | Registration | ||||
| Securities to be Registered | Registered | Per Unit | Offering Price(1) | Fee | ||||
|
7 1/2% Senior Subordinated Notes due 2013
|
$175,000,000 | 100% | 175,000,000 | $14,157.50 | ||||
|
Guarantees(2)
|
$175,000,000 | — | — | (3) | ||||
| (1) | Estimated pursuant to Rule 457(f) under the Securities Act of 1933, as amended, solely for purposes of calculating the registration fee. |
| (2) | The other companies listed in the Table of Additional Registrants below have guaranteed, jointly and severally, the 7 1/2% Senior Subordinated Notes Due 2013 being registered hereby. The Guarantors are registering the Guarantees. Pursuant to Rule 457(n) under the Securities Act of 1933, no registration fee is required with respect to the Guarantees. |
| (3) | Not applicable. |
The Registrants hereby amend this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
Select Medical Corporation
Table of Additional Registrants
| State of Incorporation | IRS Employer | |||||||
| Name | or Organization | Identification No. | ||||||
|
Affiliated Physical Therapists, Ltd.
|
Arizona | 86-0489265 | ||||||
|
Allegany Hearing and Speech, Inc.
|
Maryland | 52-1472846 | ||||||
|
American Transitional Hospitals, Inc.
|
Delaware | 76-0232151 | ||||||
|
Argosy Health, LLC
|
Delaware | 04-3436823 | ||||||
|
Athens Sports Medicine Clinic, Inc.
|
Georgia | 58-1442208 | ||||||
|
Ather Sports Injury Clinic, Inc.
|
California | 93-2539628 | ||||||
|
Atlantic Health Group, Inc.
|
Delaware | 51-0364566 | ||||||
|
Atlantic Rehabilitation Services,
Inc.
|
New Jersey | 22-2214110 | ||||||
|
Atra Services, Inc.
|
Delaware | 22-2200045 | ||||||
|
Avalon Rehabilitation & Healthcare,
L.L.C.
|
Delaware | 23-2980113 | ||||||
|
Buendel Physical Therapy, Inc.
|
Florida | 65-0008000 | ||||||
|
C.E.R. — West, Inc.
|
Michigan | 38-3027085 | ||||||
|
C.O.A.S.T. Institute Physical Therapy,
Inc.
|
California | 23-2727340 | ||||||
|
CRF Rehabilitation Associates, Inc.
|
North Carolina | 56-1608094 | ||||||
|
CCISUB, Inc.
|
North Carolina | 56-1342767 | ||||||
|
Cenla Physical Therapy & Rehabilitation
Agency, Inc.
|
Louisiana | 72-0800244 | ||||||
|
Center for Evaluation & Rehabilitation,
Inc.
|
Michigan | 38-2362109 | ||||||
|
Center for Physical Therapy & Sports
Rehabilitation, Inc.
|
New Mexico | 85-0364910 | ||||||
|
CenterTherapy, Inc.
|
Minnesota | 41-1255299 | ||||||
|
Champion Physical Therapy, Inc.
|
Pennsylvania | 25-1713794 | ||||||
|
Community Rehab Centers of Massachusetts,
Inc.
|
Massachusetts | 04-3428648 | ||||||
|
Coplin Physical Therapy Associates,
Inc.
|
Minnesota | 41-1402188 | ||||||
|
Core Rehab Management, LLC
|
Connecticut | 06-1536115 | ||||||
|
Crowley Physical Therapy Clinic, Inc.
|
Louisiana | 72-1207656 | ||||||
|
Douglas Avery & Associates, Ltd.
|
Virginia | 54-1323120 | ||||||
|
Edgewater Rehabilitation Associates,
Inc.
|
Illinois | 36-2675582 | ||||||
|
Elk County Physical Therapy, Inc.
|
Pennsylvania | 25-1694794 | ||||||
|
Fine, Bryant & Wah, Inc.
|
Maryland | 52-1022420 | ||||||
|
Francis Naselli, Jr. & Stewart Rich Physical
Therapists, Inc.
|
Pennsylvania | 23-2028573 | ||||||
|
Gallery Physical Therapy Center, Inc.
|
Minnesota | 41-1508202 | ||||||
|
Georgia Physical Therapy of West Georgia,
Inc.
|
Georgia | 58-1827718 | ||||||
|
Georgia Physical Therapy, Inc.
|
Georgia | 58-1305983 | ||||||
|
GP Therapy, L.L.C.
|
Georgia | 58-2216877 | ||||||
|
Greater Sacramento Physical Therapy Associates,
Inc.
|
California | 68-0165676 | ||||||
|
Grove City Physical Therapy and Sports Medicine,
Inc.
|
Pennsylvania | 25-1766476 | ||||||
|
Gulf Breeze Physical Therapy, Inc.
|
Florida | 59-2202550 | ||||||
|
Hand Therapy Associates, Inc.
|
Arizona | 86-0336407 | ||||||
|
Hand Therapy and Rehabilitation Associates,
Inc.
|
California | 77-0012421 | ||||||
|
Hangtown Physical Therapy, Inc.
|
California | 94-2259895 | ||||||
|
Hawley Physical Therapy, Inc.
|
California | 77-0187472 | ||||||
|
Horizon Health & Rehabilitation,
Inc.
|
Maryland | 52-1798670 | ||||||
|
Hudson Physical Therapy Services,
Inc.
|
New Jersey | 22-3144550 | ||||||
|
Human Performance and Fitness, Inc.
|
California | 93-0948981 | ||||||
|
Indianapolis Physical Therapy and Sports
Medicine, Inc.
|
Indiana | 35-1436134 | ||||||
|
Intensiva Healthcare Corporation
|
Delaware | 43-1690769 | ||||||
|
Intensiva Hospital of Greater St. Louis,
Inc.
|
Missouri | 43-1726282 | ||||||
|
Joyner Sports Science Institute, Inc.
|
Pennsylvania | 23-2888279 | ||||||
|
Joyner Sportsmedicine Institute, Inc.
|
Pennsylvania | 23-2696896 | ||||||
|
Kentucky Rehabilitation Services,
Inc.
|
Delaware | 61-1205126 | ||||||
|
Kessler Assisted Living Corporation
|
New Jersey | 22-3390033 | ||||||
|
Kessler Care Center at Cedar Grove,
Inc.
|
New Jersey | 22-3486127 | ||||||
|
Kessler Care Center at Great Falls,
Inc.
|
New Jersey | 22-3486122 | ||||||
|
Kessler Care Center at St. Cloud,
Inc.
|
New Jersey | 22-3486123 | ||||||
|
Kessler Institute for Rehabilitation,
Inc.
|
New Jersey | 22-3486125 | ||||||
|
Kessler Occupational Medicine Centers,
Inc.
|
Florida | 65-0982787 | ||||||
|
Kessler Physical Therapy & Rehabilitation,
Inc.
|
New Jersey | 22-3603168 | ||||||
|
Kessler Rehab Centers, Inc.
|
Delaware | 04-3177708 | ||||||
|
Kessler Rehab of Connecticut, Inc.
|
Connecticut | 06-1534737 | ||||||
|
Kessler Rehabilitation of Florida,
Inc.
|
Florida | 58-2451604 | ||||||
|
Kessler Rehabilitation of Maryland,
Inc.
|
Maryland | 52-2169122 | ||||||
|
Kessler Rehabilitation Corporation
|
Delaware | 22-3486128 | ||||||
|
Kessler Rehabilitation Services, Inc.
|
New Jersey | 22-3705780 | ||||||
| State of Incorporation | IRS Employer | |||||||
| Name | or Organization | Identification No. | ||||||
|
Lynn M. Carlson, Inc.
|
Arizona | 86-0429011 | ||||||
|
Metro Rehabilitation Services, Inc.
|
Michigan | 38-2371931 | ||||||
|
Michigan Therapy Centre, Inc.
|
Michigan | 38-2828917 | ||||||
|
MidAtlantic Health Group, Inc.
|
Delaware | 51-0371296 | ||||||
|
Monmouth Rehabilitation, Inc.
|
New Jersey | 22-2308963 | ||||||
|
New England Health Group, Inc.
|
Massachusetts | 04-3296305 | ||||||
|
New Mexico Physical Therapists, Inc.
|
New Mexico | 85-0284878 | ||||||
|
Northside Physical Therapy, Inc.
|
Ohio | 31-1039737 | ||||||
|
NovaCare Health Group, LLC
|
Delaware | 25-1877030 | ||||||
|
NovaCare Occupational Health Services,
Inc.
|
Delaware | 23-2884053 | ||||||
|
NovaCare Outpatient Rehabilitation East,
Inc.
|
Delaware | 23-2862027 | ||||||
|
NovaCare Outpatient Rehabilitation,
Inc.
|
Kansas | 48-0916409 | ||||||
|
NovaCare Outpatient Rehabilitation of California,
Inc.
|
California | 94-2986892 | ||||||
|
NovaCare Outpatient Rehabilitation West,
Inc.
|
Delaware | 23-2862029 | ||||||
|
NovaCare Rehabilitation, Inc.
|
Minnesota | 36-4071272 | ||||||
|
NW Rehabilitation Associates, Inc.
|
Delaware | 25-1844938 | ||||||
|
P.T. Services Company
|
Ohio | 34-1726528 | ||||||
|
P.T. Services, Inc.
|
Ohio | 34-1113297 | ||||||
|
P.T. Services Rehabilitation, Inc.
|
Ohio | 34-1222395 | ||||||
|
Pennsylvania Rehab, Inc.
|
Pennsylvania | 23-1939940 | ||||||
|
Peter Trailov R.P.T. Physical Therapy Clinic,
Orthopaedic Rehabilitation & Sports Medicine, Ltd.
|
Illinois | 36-3229108 | ||||||
|
Physical Rehabilitation Partners,
Inc.
|
Louisiana | 72-0896478 | ||||||
|
Physical Therapy Associates, P.C.
|
Massachusetts | 04-2552528 | ||||||
|
Physical Therapy Enterprises, Inc.
|
Arizona | 86-0695632 | ||||||
|
Physical Therapy Institute, Inc.
|
Louisiana | 72-1034266 | ||||||
|
Physical Therapy Services of the Jersey Cape,
Inc.
|
New Jersey | 22-3058977 | ||||||
|
Physio — Associates, Inc.
|
Pennsylvania | 25-1353511 | ||||||
|
Pro Active Therapy, Inc.
|
North Carolina | 56-1859040 | ||||||
|
Pro Active Therapy of Ahoskie, Inc.
|
North Carolina | 56-1975154 | ||||||
|
Pro Active Therapy of Gaffney, Inc.
|
South Carolina | 58-2304811 | ||||||
|
Pro Active Therapy of Greenville,
Inc.
|
North Carolina | 56-1960115 | ||||||
|
Pro Active Therapy of North Carolina,
Inc.
|
North Carolina | 56-1818102 | ||||||
|
Pro Active Therapy of Rocky Mount,
Inc.
|
North Carolina | 56-1916359 | ||||||
|
Pro Active Therapy of South Carolina,
Inc.
|
South Carolina | 58-2304502 | ||||||
|
Pro Active Therapy of Virginia, Inc.
|
Virginia | 58-2342213 | ||||||
|
Professional Therapeutic Services,
Inc.
|
Ohio | 31-0792815 | ||||||
|
Quad City Management, Inc.
|
Iowa | 42-1363158 | ||||||
|
RCI (Colorado), Inc.
|
Delaware | 84-1196213 | ||||||
|
RCI (Exertec), Inc.
|
Delaware | 23-2726794 | ||||||
|
RCI (Michigan), Inc.
|
Delaware | 23-2768957 | ||||||
|
RCI (S.P.O.R.T.), Inc.
|
Delaware | 36-3879849 | ||||||
|
RCI (WRS), Inc.
|
Delaware | 36-3879850 | ||||||
|
Rebound Oklahoma, Inc.
|
Oklahoma | 73-1386799 | ||||||
|
Redwood Pacific Therapies, Inc.
|
California | 77-0325407 | ||||||
|
Rehab Advantage, Inc.
|
Delaware | 23-2947351 | ||||||
|
Rehab Managed Care of Arizona, Inc.
|
Delaware | 23-2737890 | ||||||
|
Rehab Provider Network — California,
Inc.
|
California | 95-4418601 | ||||||
|
Rehab Provider Network — East I,
Inc.
|
Delaware | 23-2745660 | ||||||
|
Rehab Provider Network — East II,
Inc.
|
Maryland | 23-2796898 | ||||||
|
Rehab Provider Network — Georgia,
Inc.
|
Georgia | 23-2791215 | ||||||
|
Rehab Provider Network — Indiana,
Inc.
|
Indiana | 35-1900442 | ||||||
|
Rehab Provider Network — Michigan,
Inc.
|
Michigan | 23-2804801 | ||||||
|
Rehab Provider Network — New Jersey,
Inc.
|
New Jersey | 23-2745661 | ||||||
|
Rehab Provider Network — Ohio,
Inc.
|
Ohio | 23-2804807 | ||||||
|
Rehab Provider Network — Oklahoma,
Inc.
|
Oklahoma | 23-2803420 | ||||||
|
Rehab Provider Network — Pennsylvania,
Inc.
|
Pennsylvania | 23-2745659 | ||||||
|
Rehab Provider Network — Washington,
D.C., Inc.
|
District of Columbia | 23-2796900 | ||||||
|
Rehab Provider Network of Colorado,
Inc.
|
Colorado | 93-1204512 | ||||||
|
Rehab Provider Network of Florida,
Inc.
|
Florida | 65-0426653 | ||||||
|
Rehab Provider Network of Nevada,
Inc.
|
Nevada | 23-2790203 | ||||||
|
Rehab Provider Network of New Mexico,
Inc.
|
New Mexico | 74-2796295 | ||||||
|
Rehab Provider Network of North Carolina,
Inc.
|
North Carolina | 56-2099749 | ||||||
|
Rehab Provider Network of Texas, Inc.
|
Texas | 74-2796265 | ||||||
|
Rehab Provider Network of Wisconsin,
Inc.
|
Wisconsin | 36-4095936 | ||||||
|
Rehab/ Work Hardening Management Associates,
Ltd.
|
Pennsylvania | 23-2644918 | ||||||
| State of Incorporation | IRS Employer | |||||||
| Name | or Organization | Identification No. | ||||||
|
RehabClinics, Inc.
|
Delaware | 13-3595267 | ||||||
|
RehabClinics (GALAXY), Inc.
|
Illinois | 36-3382403 | ||||||
|
RehabClinics (PTA), Inc.
|
Delaware | 65-0366467 | ||||||
|
RehabClinics (SPT), Inc.
|
Delaware | 23-2736153 | ||||||
|
RehabClinics Abilene, Inc.
|
Delaware | 75-2284952 | ||||||
|
RehabClinics Dallas, Inc.
|
Delaware | 75-2422771 | ||||||
|
RehabClinics Pennsylvania, Inc.
|
Pennsylvania | 23-2800212 | ||||||
|
S.T.A.R.T., Inc.
|
Massachusetts | 04-2710250 | ||||||
|
Select Air II, Inc.
|
Delaware | 23-2972677 | ||||||
|
Select Employment Services, Inc.
|
Delaware | 25-1812245 | ||||||
|
Select Hospital Investors, Inc.
|
Delaware | 51-0402736 | ||||||
|
Select Management Services, L.L.C.
|
Delaware | 25-1805076 | ||||||
|
SelectMark, Inc.
|
Delaware | 51-0400776 | ||||||
|
Select Medical of Kentucky, Inc.
|
Delaware | 25-1820753 | ||||||
|
Select Medical of Maryland, Inc.
|
Delaware | 23-2906982 | ||||||
|
Select Medical of New Jersey, Inc.
|
Delaware | 25-1805051 | ||||||
|
Select Medical of New York, Inc.
|
Delaware | 23-2916448 | ||||||
| Delaware | 25-1820754 | |||||||
|
Select Medical of Pennsylvania, Inc.
|
Delaware | 23-2896808 | ||||||
|
Select Medical Rehabilitation Clinics,
Inc.
|
Delaware | 25-1883131 | ||||||
|
Select Provider Networks, Inc.
|
Delaware | 23-2935684 | ||||||
|
Select Rehabilitation Management Services,
Inc.
|
Delaware | 26-0030085 | ||||||
|
Select Software Ventures, L.L.C.
|
Delaware | 25-1874244 | ||||||
|
Select Specialty Hospital — Akron,
Inc.
|
Delaware | 43-1742017 | ||||||
|
Select Specialty Hospital —
Albuquerque, Inc.
|
Delaware | 65-0366469 | ||||||
|
Select Specialty Hospital — Ann Arbor,
Inc.
|
Missouri | 38-3389548 | ||||||
|
Select Specialty Hospital — Arizona,
Inc.
|
Delaware | 25-1821705 | ||||||
|
Select Specialty Hospital — Battle
Creek, Inc.
|
Missouri | 38-3389544 | ||||||
|
Select Specialty Hospital — Beech
Grove, Inc.
|
Missouri | 43-1726278 | ||||||
|
Select Specialty Hospital —
Bloomington, Inc.
|
Delaware | 25-1894394 | ||||||
|
Select Specialty Hospital — Boston,
Inc.
|
Delaware | 61-1458009 | ||||||
|
Select Specialty Hospital — Central
Detroit, Inc.
|
Delaware | 25-1862676 | ||||||
|
Select Specialty Hospital — Charleston,
Inc.
|
Delaware | 25-1866522 | ||||||
|
Select Specialty Hospital — Cincinnati,
Inc.
|
Missouri | 31-1574892 | ||||||
|
Select Specialty Hospital — Columbus,
Inc.
|
Delaware | 25-1813127 | ||||||
|
Select Specialty Hospital — Columbus/
Grant, Inc.
|
Delaware | 25-1816235 | ||||||
|
Select Specialty Hospital — Columbus/
University, Inc.
|
Missouri | 31-1476471 | ||||||
|
Select Specialty Hospital — Conroe,
Inc.
|
Delaware | 30-0160729 | ||||||
|
Select Specialty Hospital — Dallas,
Inc.
|
Delaware | 25-1813126 | ||||||
|
Select Specialty Hospital — Denver,
Inc.
|
Delaware | 76-0292237 | ||||||
|
Select Specialty Hospital — Durham,
Inc.
|
Delaware | 25-1822461 | ||||||
|
Select Specialty Hospital — Erie,
Inc.
|
Delaware | 25-1858065 | ||||||
|
Select Specialty Hospital — Escambia,
Inc.
|
Delaware | 03-0508545 | ||||||
|
Select Specialty Hospital — Evansville,
Inc.
|
Missouri | 43-1726283 | ||||||
|
Select Specialty Hospital — Flint,
Inc.
|
Missouri | 38-3329100 | ||||||
|
Select Specialty Hospital — Fort Smith,
Inc.
|
Missouri | 71-0813112 | ||||||
|
Select Specialty Hospital — Fort Wayne,
Inc.
|
Missouri | 35-1994301 | ||||||
|
Select Specialty Hospital — Gadsden,
Inc.
|
Delaware | 13-3682015 | ||||||
|
Select Specialty Hospital — Greensburg,
Inc.
|
Delaware | 25-1855814 | ||||||
|
Select Specialty Hospital — Honolulu,
Inc.
|
Hawaii | 04-3772321 | ||||||
|
Select Specialty Hospital — Houston,
Inc.
|
Delaware | 25-1813124 | ||||||
|
Select Specialty Hospital — Huntsville,
Inc.
|
Delaware | 23-2700468 | ||||||
|
Select Specialty Hospital —
Indianapolis, Inc.
|
Delaware | 25-1813123 | ||||||
|
Select Specialty Hospital — Jackson,
Inc.
|
Delaware | 25-1880780 | ||||||
|
Select Specialty Hospital — Johnstown,
Inc.
|
Missouri | 52-2110603 | ||||||
|
Select Specialty Hospital — Kansas
City, Inc.
|
Missouri | 43-1732618 | ||||||
|
Select Specialty Hospital — Knoxville,
Inc.
|
Delaware | 25-1813122 | ||||||
|
Select Specialty Hospital — Lansing,
Inc.
|
Delaware | 30-0199411 | ||||||
|
Select Specialty Hospital — Lee,
Inc.
|
Delaware | 03-0508552 | ||||||
|
Select Specialty Hospital — Leon,
Inc.
|
Delaware | 03-0508543 | ||||||
|
Select Specialty Hospital — Lexington,
Inc.
|
Delaware | 02-0631042 | ||||||
|
Select Specialty Hospital — Little
Rock, Inc.
|
Delaware | 25-1813121 | ||||||
|
Select Specialty Hospital — Louisville,
Inc.
|
Delaware | 25-1816237 | ||||||
|
Select Specialty Hospital — Macomb
County, Inc.
|
Missouri | 38-3345654 | ||||||
|
Select Specialty Hospital — Macon,
Inc.
|
Delaware | 04-3655021 | ||||||
|
Select Specialty Hospital — Marion,
Inc.
|
Delaware | 03-0508556 | ||||||
| State of Incorporation | IRS Employer | |||||||
| Name | or Organization | Identification No. | ||||||
|
Select Specialty Hospital — Memphis,
Inc.
|
Delaware | 25-1813120 | ||||||
|
Select Specialty Hospital — Milwaukee,
Inc.
|
Delaware | 25-1820734 | ||||||
|
Select Specialty Hospital — Morgantown,
Inc.
|
Delaware | 25-1855473 | ||||||
|
Select Specialty Hospital — Nashville,
Inc.
|
Delaware | 25-1813119 | ||||||
|
Select Specialty Hospital — New
Orleans, Inc.
|
Delaware | 25-1862678 | ||||||
|
Select Specialty Hospital — North
Knoxville, Inc.
|
Missouri | 62-1684861 | ||||||
|
Select Specialty Hospital — Northwest
Detroit, Inc.
|
Delaware | 25-1862677 | ||||||
|
Select Specialty Hospital — Northwest
Indiana, Inc.
|
Missouri | 43-1726280 | ||||||
|
Select Specialty Hospital — Oklahoma
City, Inc.
|
Delaware | 25-1813118 | ||||||
|
Select Specialty Hospital — Oklahoma
City/ East Campus, Inc.
|
Missouri | 43-1699215 | ||||||
|
Select Specialty Hospital — Omaha,
Inc.
|
Missouri | 47-0815478 | ||||||
|
Select Specialty Hospital — Orange,
Inc.
|
Delaware | 03-0508558 | ||||||
|
Select Specialty Hospital — Palm Beach,
Inc.
|
Delaware | 03-0508559 | ||||||
|
Select Specialty Hospital —
Philadelphia/ AEMC, Inc.
|
Missouri | 52-2075622 | ||||||
|
Select Specialty Hospital — Phoenix,
Inc.
|
Delaware | 25-1813117 | ||||||
|
Select Specialty Hospital — Pittsburgh,
Inc.
|
Missouri | 23-2911846 | ||||||
|
Select Specialty Hospital — Pontiac,
Inc.
|
Missouri | 38-3389212 | ||||||
|
Select Specialty Hospital — Reno,
Inc.
|
Missouri | 88-0383585 | ||||||
|
Select Specialty Hospital — Saginaw,
Inc.
|
Delaware | 25-1890958 | ||||||
|
Select Specialty Hospital — San
Antonio, Inc.
|
Delaware | 25-1843089 | ||||||
|
Select Specialty Hospital — Sarasota,
Inc.
|
Delaware | 23-3089963 | ||||||
|
Select Specialty Hospital — Sioux
Falls, Inc.
|
Missouri | 91-1773396 | ||||||
|
Select Specialty Hospital — South
Dallas, Inc.
|
Delaware | 25-1855474 | ||||||
|
Select Specialty Hospital — Topeka,
Inc.
|
Missouri | 74-2826467 | ||||||
|
Select Specialty Hospital — TriCities,
Inc.
|
Delaware | 25-1813125 | ||||||
|
Select Specialty Hospital — Tulsa,
Inc.
|
Delaware | 25-1813116 | ||||||
|
Select Specialty Hospital — Western
Michigan, Inc.
|
Missouri | 38-3297128 | ||||||
|
Select Specialty Hospital — Western
Missouri, Inc.
|
Delaware | 61-1458008 | ||||||
|
Select Specialty Hospital — Wichita,
Inc.
|
Missouri | 48-1196430 | ||||||
|
Select Specialty Hospital — Wilmington,
Inc.
|
Missouri | 51-0382465 | ||||||
|
Select Specialty Hospital — Wyandotte,
Inc.
|
Delaware | 25-1862675 | ||||||
|
Select Specialty Hospital — Youngstown,
Inc.
|
Missouri | 34-1880514 | ||||||
|
Select Specialty Hospital — Zanesville,
Inc.
|
Delaware | 03-0508537 | ||||||
|
Select Specialty Hospitals, Inc.
|
Delaware | 25-1813128 | ||||||
|
Select Synergos, Inc.
|
Delaware | 25-1813114 | ||||||
|
Select Transport, Inc.
|
Delaware | 23-2872899 | ||||||
|
Select Unit Management, Inc.
|
Delaware | 71-0776296 | ||||||
|
SLMC Finance Corporation
|
Delaware | 51-0406794 | ||||||
|
South Jersey Physical Therapy Associates,
Inc.
|
New Jersey | 22-2126713 | ||||||
|
South Jersey Rehabilitation and Sports Medicine
Center, Inc.
|
New Jersey | 22-2544574 | ||||||
|
South Philadelphia Occupational Health,
Inc.
|
Pennsylvania | 23-2777267 | ||||||
|
Southpointe Fitness Center, Inc.
|
Pennsylvania | 25-1760081 | ||||||
|
Southwest Emergency Associates, Inc.
|
Arizona | 86-0376633 | ||||||
|
Southwest Physical Therapy, Inc.
|
New Mexico | 85-0333685 | ||||||
|
Southwest Therapists, Inc.
|
New Mexico | 85-0278777 | ||||||
|
Sports & Orthopedic Rehabilitation Services,
Inc.
|
Florida | 59-2922487 | ||||||
|
Stephenson-Holtz, Inc.
|
California | 77-0325407 | ||||||
|
The Center for Physical Therapy and
Rehabilitation, Inc.
|
New Mexico | 85-0349202 | ||||||
|
The Orthopedic Sports and Industrial
Rehabilitation Network, Inc.
|
Pennsylvania | 23-2626897 | ||||||
|
TJ Partnership I
|
Florida | 23-2827568 | ||||||
|
Treister, Inc.
|
Ohio | 34-1021034 | ||||||
|
Valley Group Physical Therapists,
Inc.
|
Pennsylvania | 23-2081856 | ||||||
|
Vanguard Rehabilitation, Inc.
|
Arizona | 86-0490865 | ||||||
|
Victoria Healthcare, Inc.
|
Florida | 25-1897325 | ||||||
|
Wayzata Physical Therapy Center, Inc.
|
Minnesota | 41-1529147 | ||||||
|
West Penn Rehabilitation Services,
Inc.
|
Pennsylvania | 25-1504470 | ||||||
|
West Side Physical Therapy, Inc.
|
Ohio | 31-1182791 | ||||||
|
West Suburban Health Partners, Inc.
|
Minnesota | 41-1631716 | ||||||
|
Wilpage, Inc.
|
New Jersey | 22-2739039 | ||||||
|
Yuma Rehabilitation Center, Inc.
|
Arizona | 86-0470129 | ||||||
The address, including zip code, and telephone number, including area code, of the principal offices of the additional registrants listed above (the “Additional Registrants”) is 4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, Pennsylvania 17055. The telephone number at that address is (717) 972-1100.
| The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted. |
SUBJECT TO COMPLETION, DATED OCTOBER 17, 2003
PROSPECTUS
OFFER TO EXCHANGE
7 1/2% Senior Subordinated Notes Due 2013 originally issued by Select Medical Escrow, Inc. for new 7 1/2% Senior Subordinated Notes Due 2013
of
SELECT MEDICAL CORPORATION
THE EXCHANGE OFFER WILL EXPIRE AT 5:00 P.M.,
Terms of the exchange offer:
| • | We will exchange all old notes that are validly tendered and not withdrawn prior to the expiration of the exchange offer. | |
| • | You may withdraw tenders of old notes at any time prior to the expiration of the exchange offer. | |
| • | We believe that the exchange of old notes will not be a taxable event for U.S. federal income tax purposes, but you should see “Certain United States federal income tax considerations” on page 167 for more information. | |
| • | We will not receive any proceeds from the exchange offer. | |
| • | The terms of the new notes are substantially identical to the old notes, except that the new notes are registered under the Securities Act of 1933 and the transfer restrictions and registration rights applicable to the old notes do not apply to the new notes. |
See “Risk Factors” beginning on page 17 for a discussion of risks that should be considered by holders prior to tendering their old notes.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
The date of this prospectus is , 2003.
In making your investment decision, you should rely only on the information contained in this prospectus. We have not authorized anyone to provide you with any other information. If you receive any other information, you should not rely on it.
You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front cover of this prospectus. The information on our website, located at www.selectmedicalcorp.com, is not part of this prospectus.
Our principal executive offices are located at 4716 Old Gettysburg Road, Mechanicsburg, Pennsylvania, and our telephone number at that address is (717) 972-1100. Our common stock is listed on the New York Stock Exchange under the symbol “SEM.”
Each broker-dealer that receives new notes for its own account pursuant to the exchange offer must acknowledge that it will deliver a prospectus in connection with any resale of new notes. The Letter of Transmittal states that by so acknowledging and by delivering a prospectus, a broker-dealer will not be deemed to admit that it is an “underwriter” within the meaning of the Securities Act of 1933, which we refer to as the Securities Act. This prospectus, as it may be amended or supplemented from time to time, may be used by a broker-dealer in connection with resales of new notes received in exchange for old notes where the old notes were acquired by the broker-dealer as a result of market-making activities or other trading activities. We have agreed that, for a period of 180 days after the expiration date, we will make this prospectus available to any broker-dealer for use in connection with any such resale. See “Plan of distribution.”
Industry and market data
In this prospectus we rely on and refer to information and statistics regarding the healthcare industry. We obtained this information and these statistics from various third-party sources, discussions with our customers and our own internal estimates. We believe that these sources
i
Forward-looking statements
Statements contained in this prospectus that are not historical facts may be forward-looking statements within the meaning of U.S. federal securities law. These statements include, without limitation, statements preceded by, followed by or that include the words “believes,” “expects,” “anticipates,” “estimates,” or similar expressions. Such forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available to management. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The following factors are among those that may cause actual results to differ materially from the forward-looking statements:
| • | a change in government reimbursement for our services that would affect our revenue; | |
| • | the failure of our long term acute care hospitals to maintain their status as such, which could negatively impact our profitability; | |
| • | a government investigation or assertion that we have violated applicable regulations may result in increased costs and a significant use of internal resources; | |
| • | shortages in qualified nurses could increase our operating costs significantly; | |
| • | the effect of liability and other claims asserted against us; | |
| • | conditions in the malpractice insurance market may further increase the cost of malpractice insurance and/or force us to assume even higher self-insured retentions; | |
| • | private third party payors of our services may undertake cost containment initiatives that would decrease our revenue; | |
| • | unexpected difficulties in integrating our and Kessler’s operations or realizing the anticipated benefits from the Kessler Acquisition (as described herein); | |
| • | unforeseen liabilities associated with the Kessler Acquisition; and | |
| • | future acquisitions may use significant resources and expose us to unforeseen risks. |
All subsequent written and oral forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements set forth or referred to above. We are not obligated to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
ii
Summary
The summary highlights information contained elsewhere in this prospectus. You should read the entire prospectus carefully, including the financial statements and related notes and the risks of investing discussed under “Risk factors,” before investing.
In this prospectus, “Company,” “Select,” “we,” “our,” and “us,” except as otherwise indicated or as the context otherwise indicates, refer to Select Medical Corporation. With respect to the descriptions of our business contained in this prospectus, such terms refer to Select Medical Corporation and our subsidiaries. The terms “Select Medical Escrow” refers to Select Medical Escrow, Inc., “Kessler” refers to Kessler Rehabilitation Corporation and its subsidiaries and the term “Kessler Acquisition” refers to our acquisition of Kessler as described under the caption “Our business— the Kessler Acquisition.”
The Exchange Offer
On July 29, 2003, Select Medical Escrow issued and sold $175.0 million aggregate principal amount of 7 1/2% Senior Subordinated Notes Due 2013, referred to as the old notes. In connection with that sale, Select and Select Medical Escrow entered into a registration rights agreement with the initial purchasers of the old notes in which we agreed to deliver this prospectus to you and to complete an exchange offer for the old notes. On September 2, 2003, Select Medical Escrow was merged with and into Select—and the separate corporate existence of Select Medical Escrow ceased as of that date and Select assumed all of the obligations and responsibilities of Select Medical Escrow under the old notes. As required by the registration rights agreement, Select is offering to exchange $175.0 million aggregate principal amount of our new 7 1/2% Senior Subordinated Notes Due 2013, referred to as the new notes, the issuance of which will be registered under the Securities Act, for a like aggregate principal amount of old notes. We refer to this offer to exchange new notes for old notes in accordance with the terms set forth in this prospectus and the accompanying letter of transmittal as the exchange offer. You are entitled to exchange your old notes for new notes. We urge you to read the discussions under the headings “The exchange offer” and “The new notes” in this Summary for further information regarding the exchange offer and the new notes.
Company overview
We are a leading operator of specialty hospitals for long term stay patients in the United States. We are also a leading operator of outpatient rehabilitation clinics in the United States and Canada. As of June 30, 2003, we operated 75 long term acute care hospitals in 24 states and 737 outpatient rehabilitation clinics in 32 states, the District of Columbia and seven Canadian provinces. We began operations in 1997 under the leadership of our current management team, including our co-founders, Rocco A. Ortenzio and Robert A. Ortenzio, both of whom have significant experience in the healthcare industry. Under this leadership, we have grown our business through strategic acquisitions and internal development initiatives, increasing net operating revenue, net income (loss) and EBITDA (as defined in “—Summary of consolidated financial and other data”) from $456.0 million, $(13.1) million and $27.5 million, respectively, for the fiscal year ended December 31, 1999 to $1,126.6 million, $44.2 million and $125.3 million for the fiscal year ended December 31, 2002.
1
Recent developments
Kessler Acquisition
On September 2, 2003, we completed the acquisition of all of the outstanding stock of Kessler Rehabilitation Corporation from Henry H. Kessler Foundation, Inc. for $228.3 million in cash, and $1.7 million of assumed indebtedness. The purchase price is subject to a post-closing working capital adjustment as described under the caption “Our business— the Kessler Acquisition.” Through its network of five rehabilitation hospital facilities and 92 outpatient clinics, Kessler is one of the nation’s leading providers of comprehensive rehabilitation care and physical medicine services. As of June 30, 2003, pro forma for the Kessler Acquisition, we would have operated 80 specialty hospitals and 829 outpatient rehabilitation clinics. Additionally, on a pro forma basis, we would have generated net operating revenues, net income and EBITDA of $757.2 million, $29.5 million and $88.6 million, respectively, for the six months ended June 30, 2003.
Select Medical Corporation
We operate our business to satisfy a broad range of healthcare needs through the following divisions:
Specialty hospitals/other (60% of net operating revenue for the six months ended June 30, 2003)
Our long term acute care hospitals treat patients with serious and often complex medical conditions such as respiratory failure, neuromuscular disorders, cardiac disorders, non-healing wounds, renal disorders and cancer. Patients are admitted to our long term acute care hospitals from general acute care hospitals in our markets. The differences in clinical expertise and reimbursement rates provide general acute care hospitals and their physicians with incentives to discharge longer stay, medically complex patients to our facilities. Nearly all of our existing facilities are located in leased space within general acute care hospitals. The leased spaces are commonly referred to as a “hospital within a hospital.” We believe this model provides several advantages to patients, host hospitals, physicians and us:
| • | Patients benefit from being in a setting specialized to meet their unique medical needs; | |
| • | In addition to being provided with a place to discharge high-cost, long-stay patients, host hospitals benefit by receiving payments from us for rent and ancillary services; | |
| • | Physicians affiliated with the host hospital are provided with the convenience of being able to monitor the progress of their patients without traveling to another location; and | |
| • | We benefit from the ability to operate specialty hospitals without the capital investment often associated with buying or building a freestanding facility. We also gain operating cost efficiencies by contracting with these host hospitals for selected services at discounted rates. |
2
Outpatient rehabilitation (40% of net operating revenues for the six months ended June 30, 2003)
Our outpatient rehabilitation clinics provide physical, occupational and speech therapy typically to patients with musculoskeletal impairments that restrict their ability to perform normal activities of daily living. We also provide rehabilitation management services and staffing on a contract basis to other healthcare providers. Patients are generally referred or directed to our clinics by a physician, employer or health insurer who believes that a patient can benefit from our services. We believe that our services are attractive to healthcare payors who are seeking to provide the most cost-effective level of care to their enrollees.
Kessler Rehabilitation Corporation
Kessler provides the following services:
Specialty hospitals (54% of Kessler’s revenues for the six months ended June 30, 2003)
Kessler’s specialty hospital services are delivered through four free-standing rehabilitation hospital facilities in New Jersey. In these facilities, Kessler provides services to patients who require intensive rehabilitative care for debilitating injuries including traumatic brain and spinal cord injuries. Patients in Kessler’s specialty hospitals generally require longer stays and a more specialized level of clinical attention than individuals in general acute care hospital settings. Kessler also has a 50% ownership position in a rehabilitation hospital in Maryland which it operates with a joint venture partner. Kessler accounts for this joint venture under the equity method of accounting for investments.
Outpatient rehabilitation (35% of Kessler’s revenues for the six months ended June 30, 2003)
Outpatient rehabilitation services are provided through 92 outpatient rehabilitation clinics. At these clinics, Kessler provides physical, occupational and speech therapy to patients who require rehabilitation services but are well enough to be treated outside of an inpatient setting. Kessler’s clinics are located throughout 10 states in the eastern United States. Additionally, Kessler provides onsite contract rehabilitation services to individuals in third-party institutions such as schools, nursing homes, assisted living facilities, hospitals and the workplace.
Other services (11% of Kessler’s revenues for the six months ended June 30, 2003)
Other services include the sale of home medical equipment, orthotics, prosthetics, oxygen and ventilator systems and infusion/intravenous services. Kessler also operates a 196-bed skilled nursing facility located in New Jersey.
We believe that the Kessler Acquisition provides us significant benefits including:
| • | Highly regarded brand name. Kessler has built a strong reputation and is widely recognized for its leadership in providing quality, comprehensive rehabilitation services. Notably, Kessler’s rehabilitation hospital network, Kessler Institute for Rehabilitation, was ranked as the top rehabilitation hospital in the northeastern United States in 2002, according to a survey of board-certified physicians that was published by U.S. News & World Report. We expect that this strong brand name will enhance our ability to attract patients and strengthen our referral relationships. | |
| • | Comparable specialty hospital business. Kessler’s rehabilitation hospital facilities represent a strong fit with our existing long term acute care hospital business. Both Kessler’s rehabilitation hospital facilities and our long term acute care hospitals |
3
| provide specialized care to their patient populations and have similar business fundamentals. The addition of Kessler’s rehabilitation hospitals will allow us to reach a broader array of patients and will provide us with an additional platform for future growth. |
| • | Greater scale in outpatient rehabilitation. Kessler’s outpatient rehabilitation clinics will provide additional scale to our existing outpatient business, particularly in the eastern United States. Our total number of facilities as of June 30, 2003, pro forma for the Kessler Acquisition, would have increased from 737 to 829. We believe scale enhances our referral network and our ability to negotiate favorable contracts with commercial insurers. | |
| • | Leverage our management team’s expertise. Our management team has extensive experience operating both outpatient rehabilitation clinics and specialty hospitals licensed as rehabilitation hospitals. Prior to co-founding Select, our Executive Chairman, Rocco Ortenzio, and our President and Chief Executive Officer, Robert Ortenzio co-founded Continental Medical Systems, Inc. (“CMSI”) a publicly traded rehabilitation hospital company. They managed and developed this company from its inception in 1986 until it was sold in 1995. |
Competitive strengths
| • | Leading market position. Since beginning our operations in 1997, we believe that we have developed a reputation as a high quality, cost-effective health care provider in the markets we serve. We are a leading operator of specialty hospitals for long term stay patients in the United States and a leading operator of outpatient rehabilitation clinics in the United States and Canada. As of June 30, 2003, we operated 75 long term acute care hospitals with 2,758 available licensed beds in 24 states, and we also operated 737 outpatient rehabilitation clinics in 32 states, the District of Columbia and seven Canadian provinces. The Kessler Acquisition provides five inpatient rehabilitation facilities, an additional 92 outpatient rehabilitation clinics and a widely recognized brand name with a high quality reputation. Our leadership position allows us to attract patients, aids us in our marketing efforts to payors and referral sources and helps us negotiate favorable payor contracts. | |
| • | Experienced and proven management team. Prior to co-founding Select and CMSI, our Executive Chairman founded and operated two other healthcare companies focused on rehabilitation services. Our five senior operations executives have an average of 25 years of experience in the healthcare industry. In addition, 17 of the Company’s 28 officers previously worked together at CMSI. | |
| • | Proven financial performance. We have established a track record of improving the performance of the facilities we operate. A significant reason for our strong operating performance over the past several years has been our disciplined approach to growth and intense focus on cash flow generation and debt reduction: |
| — | net operating revenues, net income (loss) and EBITDA (excluding the Kessler Acquisition) have grown from $456.0 million, $(13.1) million and $27.5 million, respectively, for the fiscal year ended December 31, 1999 to $1,126.6 million, $44.2 million and $125.3 million, respectively, for the fiscal year ended December 31, 2002; |
4
| — | accounts receivable days outstanding have decreased from 119 as of December 31, 1999 to 56 as of June 30, 2003; and | |
| — | our ability to reduce our ratio of total debt to EBITDA from 3.7x as of December 31, 2000 to 2.1x as of December 31, 2002. |
| • | Experience in successfully completing and integrating acquisitions. Since we began operations in 1997, we have completed three significant acquisitions for approximately $366.4 million in aggregate consideration (not including the Kessler Acquisition). We believe that we have significantly improved the operating performance of the facilities we have acquired by applying our standard operating practices to the acquired businesses. | |
| • | Significant scale. By building significant scale in our specialty hospitals and outpatient rehabilitation clinics, we have been able to leverage our operating costs by centralizing administrative functions at our corporate office. Additionally, we believe that our size improves our ability to negotiate favorable outpatient contracts with commercial insurers. | |
| • | Multiple business lines and geographic diversity. We have a leading presence in two attractive segments of the healthcare industry, which we believe diversifies our business risk. Because we provide inpatient care in our specialty hospitals and outpatient care in our rehabilitation clinics, we do not rely exclusively on a single business line for our net operating revenues, operating profits or EBITDA. Our geographic diversification and the mix of our business also reduces our exposure to any single governmental or commercial reimbursement source. | |
| • | Demonstrated development expertise. From our inception through June 30, 2003, we have developed 40 new long term acute care hospitals and 164 outpatient rehabilitation clinics. These initiatives have demonstrated our ability to effectively identify new opportunities and implement start-up plans. |
Our strategy
Specialty hospitals
The key elements of our specialty hospital strategy are to:
| • | Provide high quality and cost effective care. To effectively address the complex nature of our patients’ medical conditions, we have developed specialized treatment programs focused on their needs. Additionally, our staffing models are designed to ensure that patients have access to the necessary level of clinical attention and that our resources are being deployed in an efficient, cost- effective manner. The quality of the patient care we provide is continually monitored using several measures including clinical outcomes as well as patient, payor and physician satisfaction surveys. | |
| • | Reduce operating costs. We continually seek to improve operating efficiency and reduce costs at our hospitals by standardizing and centralizing key administrative functions. We believe that by optimizing staffing based on our occupancy and the clinical needs of our patients, we can lower our variable cost per patient. Additionally, as part of our operating philosophy, we continue to focus on initiatives that will reduce expenses, such as group purchasing arrangements to receive discounts for pharmaceutical and medical supplies. |
5
| • | Increase higher margin commercial volume. We typically receive higher reimbursement rates from commercial insurers than we do from the federal Medicare program. As a result, we work to expand relationships with insurers to increase commercial patient volume. Although the level of care we provide is complex and staff intensive, we typically have lower operating expenses at our existing hospitals because we provide a much narrower range of patient services than a general acute care hospital. As a result of these lower costs, we offer more attractive rates to commercial payors. We also believe that we offer commercial enrollees customized treatment programs not offered in traditional acute care facilities. | |
| • | Develop new long term acute care hospitals. Our goal is to develop 8 to 10 new long term acute care hospitals each year using primarily our “hospital within a hospital” model by leasing space from general acute care hospitals with leading market positions. We seek to contract with various types of general acute care hospitals, including for-profit, not-for-profit and university affiliates. We intend to continue to expand our high quality facility base while maintaining our high standards of care. | |
| • | Pursue opportunistic acquisitions. In addition to our development initiatives, we intend to grow our network of specialty hospitals through strategic acquisitions. We adhere to selective criteria in our analysis and have historically been able to obtain assets for what we believe are attractive valuations. We have a focused team of professionals that formulates and executes an integration plan, and we have generally been able to increase margins at acquired facilities by streamlining various functions and standardizing our staffing models. |
Outpatient rehabilitation
The key elements of our outpatient rehabilitation strategy are to:
| • | Increase market share. Having a strong market share in our local markets allows us to benefit from heightened brand awareness, economies of scale and increased leverage when negotiating payor contracts. To increase our market share, we seek to expand the services and programs we provide and generate loyalty with patients and referral sources by providing high quality care and strong customer service. We intend to leverage the scale we will achieve through the acquisition of the Kessler outpatient clinics to enhance this strategy. | |
| • | Optimize the profitability of our payor contracts. We continually review new and existing payor contracts to determine how each of the contracts affects our profitability. We create a retention strategy for each of our top performing contracts and a re-negotiation strategy for contracts that do not meet our defined criteria. | |
| • | Grow through new development and acquisitions. We intend to open new clinics in our current markets where we believe we can benefit from existing referral relationships and brand awareness to produce incremental growth and operating leverage. Additionally, we intend to continually evaluate acquisition opportunities, such as Kessler, that may enhance the scale of our business and expand our geographic reach. | |
| • | Maintain strong employee relations. We seek to retain, motivate and educate our employees whose relationships with referral sources, such as physicians and healthcare case managers, are key to our success. We attempt to motivate them by implementing |
6
| a performance-based program, a defined career path, timely and open communication on company developments, and internal training programs. We also focus on empowering our employees by giving them a high degree of autonomy in determining local market strategy. This management approach reflects the unique nature of each market we operate in and the importance of encouraging our employees to assume responsibility for their clinic’s performance. |
7
The exchange offer
| Notes offered | $175,000,000 aggregate principal amount of 7 1/2% Senior Subordinated Notes Due 2013 of Select Medical Corporation. The terms of the new notes and old notes are identical in all material respects, except for transfer restrictions and registration rights relating to the old notes. | |
| The exchange offer | We are offering the new notes to you in exchange for a like principal amount of old notes. Old notes may be exchanged only in integral multiples of $1,000. We intend by the issuance of the new notes to satisfy our obligations contained in the Exchange and Registration Rights Agreement. | |
| Expiration date; Withdrawal of tender | The exchange offer will expire at 5:00 p.m., New York City time, on , 2003, or such later date and time to which it may be extended by us. The tender of old notes pursuant to the exchange offer may be withdrawn at any time prior to the expiration date of the exchange offer. Any old notes not accepted for exchange for any reason will be returned without expense to the tendering holder thereof as promptly as practicable after the expiration or termination of the exchange offer. | |
| Conditions to the exchange offer | Our obligation to accept for exchange, or to issue new notes in exchange for, any old notes is subject to customary conditions relating to compliance with any applicable law or any applicable interpretation by the staff of the Securities and Exchange Commission, the receipt of any applicable governmental approvals and the absence of any actions or proceedings of any governmental agency or court which could materially impair our ability to consummate the exchange offer. We currently expect that each of the conditions will be satisfied and that no waivers will be necessary. See “The exchange offer— Conditions to the exchange offer.” | |
| Procedures for tendering old notes | If you wish to accept the exchange offer and tender your old notes, you must complete, sign and date the Letter of Transmittal, or a facsimile of the Letter of Transmittal, in accordance with its instructions and the instructions in this prospectus, and mail or otherwise deliver such Letter of Transmittal, or the facsimile, together with the old notes and any other required documentation, to the exchange agent at the address set forth herein. See “The exchange offer— Procedures for tendering old notes.” | |
| Use of proceeds | We will not receive any proceeds from the exchange offer. | |
| Exchange agent | U.S. Bank Trust National Association is serving as the exchange agent in connection with the exchange offer. |
8
| Federal income tax Consequences | The exchange of notes pursuant to the exchange offer should not be a taxable event for federal income tax purposes. See “Certain United States federal income tax consequences.” |
9
Consequences of exchanging old notes pursuant to the exchange offer
Based on certain interpretive letters issued by the staff of the Securities and Exchange Commission to third parties in unrelated transactions, we are of the view that holders of old notes (other than any holder who is an “affiliate” of our company within the meaning of Rule 405 under the Securities Act) who exchange their old notes for new notes pursuant to the exchange offer generally may offer the new notes for resale, resell such new notes and otherwise transfer the new notes without compliance with the registration and prospectus delivery provisions of the Securities Act, provided:
| • | the new notes are acquired in the ordinary course of the holders’ business; | |
| • | the holders have no arrangement with any person to participate in a distribution of the new notes; and | |
| • | neither the holder nor any other person is engaging in or intends to engage in a distribution of the new notes. |
Each broker-dealer that receives new notes for its own account in exchange for old notes must acknowledge that it will deliver a prospectus in connection with any resale of the new notes. See “Plan of distribution.” In addition, to comply with the securities laws of applicable jurisdictions, the new notes may not be offered or sold unless they have been registered or qualified for sale in the applicable jurisdiction or in compliance with an available exemption from registration or qualification. We have agreed, under the Exchange and Registration Rights Agreement and subject to limitations specified in the Exchange and Registration Rights Agreement, to register or qualify the new notes for offer or sale under the securities or blue sky laws of the applicable jurisdictions as any holder of the notes reasonably requests in writing. If a holder of old notes does not exchange the old notes for new notes according to the terms of the exchange offer, the old notes will continue to be subject to the restrictions on transfer contained in the legend printed on the old notes. In general, the old notes may not be offered or sold, unless registered under the Securities Act, except under an exemption from, or in a transaction not subject to, the Securities Act and applicable state securities laws. Holders of old notes do not have any appraisal or dissenters’ rights under the Delaware General Corporation Law in connection with the exchange offer. See “The exchange offer— consequences of failure to exchange; Resales of new notes.”
The old notes are currently eligible for trading in the Private Offerings, Resales and Trading through Automated Linkages (PORTAL) market. Following commencement of the exchange offer but prior to its completion, the old notes may continue to be traded in the PORTAL market. Following completion of the exchange offer, the new notes will not be eligible for PORTAL trading.
10
The new notes
The terms of the new notes and the old notes are identical in all material respects, except for transfer restrictions and registration rights relating to the old notes.
| Issuer | Select Medical Corporation | |
| Maturity date | August 1, 2013. | |
| Interest payment dates | August 1 and February 1 of each year, commencing February 1, 2004. | |
| Optional redemption | On or after August 1, 2008, Select may redeem some or all of the new notes at the redemption prices listed in the section entitled “Description of notes— Optional redemption.” Select may not redeem the new notes before August 1, 2008, except that at any time before August 1, 2006, Select may redeem up to 35% of the original principal amount of the new notes with the proceeds of certain offerings of common equity at a redemption price equal to 107.5% of the principal amount of the new notes, together with accrued and unpaid interest, so long as 65% of the original principal amount of the new notes remain outstanding after each permitted redemption made with equity proceeds. | |
| Change of control | Upon a change of control, each holder of the new notes may require Select to repurchase such holder’s notes, in whole or in part, at a purchase price equal to 101% of the principal amount thereof plus accrued and unpaid interest to the purchase date. | |
| Guarantees | Substantially all of Select’s operations are conducted through its subsidiaries. Select’s obligations under the new notes will be fully and unconditionally guaranteed on a senior subordinated basis by all of its wholly owned domestic subsidiaries. For the twelve months ended June 30, 2003, Select’s wholly owned domestic subsidiaries generated 85.2% of Select’s EBITDA, as defined in the Indenture, (or 87.4% on a pro forma basis for the Kessler Acquisition and the issuance of the old notes). At June 30, 2003, those subsidiaries represented approximately 84.0% of Select’s total assets (or 87.3% on a pro forma basis for the Kessler Acquisition and the issuance of the old notes). | |
| Ranking | The new notes will be subordinated in right of payment to all of Select’s existing and future senior indebtedness, including Select’s obligations in respect of the senior credit facility. The guarantees of the new notes will be subordinated in right of payment to all existing and future senior indebtedness of the subsidiary guarantors, including any borrowings or guarantees by those subsidiaries under the senior credit facility. The new notes will rank equally in right of payment with all of Select’s existing and future senior subordinated indebtedness, including the existing 9 1/2% senior subordinated notes and the old notes, and senior to all of Select’s existing and future subordinated indebtedness. The guarantees of the new notes will rank equally in right of payment with all senior subordinated |
11
| indebtedness including guarantees of the old notes and senior to all subordinated indebtedness of the subsidiary guarantors. |
| As of June 30, 2003, on a pro forma basis for the Kessler Acquisition and the sale of the old notes, Select (excluding its subsidiaries) would have had approximately $45.7 million of indebtedness to which the new notes would have been subordinated. This amount includes $39.9 million in borrowings and $5.7 million of outstanding letters of credit under Select’s senior credit facility but does not include up to an additional $146.7 million available to Select and its subsidiaries under its senior credit facility. As of June 30, 2003, on a pro forma basis for the Kessler Acquisition and the sale of the old notes, Select’s subsidiary guarantors would have had $50.0 million of guarantor senior debt to which their respective guarantees as to the new notes would be subordinated. | ||
| As of June 30, 2003, on a pro forma basis for the Kessler Acquisition and the sale of the old notes, Select (excluding its subsidiaries) had $175.0 million of senior subordinated indebtedness with which the new notes would rank equally. | ||
| As of June 30, 2003, on a pro forma basis for the Kessler Acquisition and the sale of the old notes, the subsidiary guarantors would have had $177.3 million of guarantor senior subordinated debt with which its respective guarantees of the new notes would rank equally and no guarantor subordinated debt with which their respective guarantees would rank senior. | ||
| Certain covenants | The new notes are governed by an indenture with U.S. Bank Trust National Association as trustee. The indenture, among other things, restricts our ability to: | |
| • incur additional debt; | ||
| • incur debt that is junior to our senior debt but senior to the notes; | ||
| • pay dividends and redeem stock or redeem subordinated debt; | ||
| • incur or permit to exist certain liens; | ||
| • enter into agreements that restrict dividends from subsidiaries; | ||
| • sell assets; | ||
| • enter into transactions with affiliates; | ||
| • sell capital stock of subsidiaries; | ||
| • merge or consolidate; and | ||
| • enter different lines of business. | ||
| The covenants listed above are subject to certain exceptions and limitations described in the indenture. |
You should refer to the section entitled “Risk factors” for an explanation of certain risks in investing in the new notes.
12
Summary consolidated financial and other data
You should read the summary consolidated financial and other data below in conjunction with our consolidated financial statements and the accompanying notes and the unaudited pro forma combined financial information, contained herein. We derived the historical financial data for the years ended December 31, 2000, 2001 and 2002, and as of December 31, 2000, 2001 and 2002 from our audited consolidated financial statements. We derived the historical financial data for the six months ended June 30, 2002 and June 30, 2003, and as of June 30, 2002 and 2003, from our unaudited interim consolidated financial statements. You should also read “Selected consolidated financial and other data” and the accompanying “Management’s discussion and analysis of financial condition and results of operations.” All of these materials are contained later in this offering memorandum. The unaudited pro forma combined statement of operations data for the year ended December 31, 2002 present results of operations before cumulative effects of accounting changes and are pro forma for the Kessler Acquisition and the sale of the old notes as if these transactions had been completed on January 1, 2002. The unaudited pro forma combined statements of operations data for the six months ended June 30, 2003 are pro forma for the Kessler Acquisition and the sale of the old notes as if these transactions had been completed on January 1, 2003. The unaudited pro forma combined balance sheet data as of June 30, 2003 are pro forma for the Kessler Acquisition and the sale of the old notes as if these transactions had been completed on June 30, 2003. You should also read “Unaudited pro forma combined financial information.” The pro forma information shown below as part of the “Summary consolidated financial and other data,” is presented to be consistent with the information presented in “Unaudited pro forma combined financial information.”
13
| Six months ended | ||||||||||||||||||||||||||||
| Year ended December 31, | June 30, | |||||||||||||||||||||||||||
| Pro forma | Pro forma | |||||||||||||||||||||||||||
| (Dollars in thousands) | 2000 | 2001 | 2002 | 2002 | 2002 | 2003 | 2003 | |||||||||||||||||||||
|
Consolidated statement of operations
data:
|
||||||||||||||||||||||||||||
|
Net operating revenues
|
$ | 805,897 | $ | 958,956 | $ | 1,126,559 | $ | 1,354,194 | $ | 552,192 | $ | 638,525 | $ | 757,157 | ||||||||||||||
|
Operating expenses(a)
|
714,227 | 846,938 | 999,280 | 1,192,741 | 487,950 | 556,134 | 667,147 | |||||||||||||||||||||
|
Depreciation and amortization
|
30,401 | 32,290 | 25,836 | 37,701 | 12,206 | 14,706 | 21,146 | |||||||||||||||||||||
|
Income from operations
|
61,269 | 79,728 | 101,443 | 123,752 | 52,036 | 67,685 | 68,864 | |||||||||||||||||||||
|
Loss on early retirement of debt(b)
|
6,247 | 14,223 | - | - | - | - | - | |||||||||||||||||||||
|
Equity in (income) loss from joint ventures
|
- | - | - | 889 | - | - | (160 | ) | ||||||||||||||||||||
|
Interest expense, net
|
35,187 | 29,209 | 26,614 | 40,555 | 13,386 | 11,706 | 18,894 | |||||||||||||||||||||
|
Income before minority interests and income taxes
|
19,835 | 36,296 | 74,829 | 82,308 | 38,650 | 55,979 | 50,130 | |||||||||||||||||||||
|
Minority interests(c)
|
4,144 | 3,491 | 2,022 | 2,022 | 1,173 | 1,537 | 1,537 | |||||||||||||||||||||
|
Income before income taxes
|
15,691 | 32,805 | 72,807 | 80,286 | 37,477 | 54,442 | 48,593 | |||||||||||||||||||||
|
Income tax provision
|
9,979 | 3,124 | 28,576 | 32,431 | 14,700 | 21,357 | 19,132 | |||||||||||||||||||||
|
Net income
|
5,712 | 29,681 | 44,231 | 47,855 | 22,777 | 33,085 | 29,461 | |||||||||||||||||||||
|
Less: Preferred dividends
|
8,780 | 2,513 | - | - | - | - | - | |||||||||||||||||||||
|
Net income (loss) available to common stockholders
|
$ | (3,068 | ) | $ | 27,168 | $ | 44,231 | $ | 47,855 | $ | 22,777 | $ | 33,085 | $ | 29,461 | |||||||||||||
|
Other financial data:
|
||||||||||||||||||||||||||||
|
EBITDA(d)
|
$ | 81,279 | $ | 94,304 | $ | 125,257 | $ | 158,542 | $ | 63,069 | $ | 80,854 | $ | 88,633 | ||||||||||||||
|
EBITDA as a % of net operating revenue
|
10.1% | 9.8% | 11.1% | 11.7% | 11.4% | 12.7% | 11.7% | |||||||||||||||||||||
|
Capital expenditures
|
$ | 22,430 | $ | 24,011 | $ | 43,183 | $ | 17,948 | $ | 15,206 | ||||||||||||||||||
|
Cash flow data:
|
||||||||||||||||||||||||||||
|
Cash flow provided by operating activities
|
$ | 22,513 | $ | 95,770 | $ | 120,812 | $ | 50,475 | $ | 91,272 | ||||||||||||||||||
|
Cash flow provided by (used in) investing
activities
|
14,197 | (61,947 | ) | (54,048 | ) | (21,787 | ) | (17,021 | ) | |||||||||||||||||||
|
Cash flow (used in) financing activities
|
(37,616 | ) | (26,164 | ) | (21,423 | ) | (10,629 | ) | (39,311 | ) | ||||||||||||||||||
|
Balance sheet data (at end of
period):
|
||||||||||||||||||||||||||||
|
Cash and cash equivalents
|
$ | 3,151 | $ | 10,703 | $ | 56,062 | $ | 28,834 | $ | 91,351 | $ | 26,471 | ||||||||||||||||
|
Working capital
|
105,567 | 126,749 | 130,621 | 133,019 | 146,070 | 109,086 | ||||||||||||||||||||||
|
Total assets
|
586,800 | 650,845 | 739,059 | 693,433 | 737,860 | 948,862 | ||||||||||||||||||||||
|
Total debt
|
302,788 | 288,423 | 260,217 | 272,875 | 223,943 | 400,696 | ||||||||||||||||||||||
|
Preferred stock
|
129,573 | - | - | - | - | |||||||||||||||||||||||
|
Total stockholders’ equity
|
48,498 | 234,284 | 286,418 | 265,028 | 326,539 | 326,539 | ||||||||||||||||||||||
|
Selected ratios:
|
||||||||||||||||||||||||||||
|
Ratio of EBITDA to net interest
|
2.3 | x | 3.2 | x | 4.7 | x | ||||||||||||||||||||||
|
Ratio of total debt to EBITDA
|
3.7 | x | 3.1 | x | 2.1 | x | ||||||||||||||||||||||
|
Ratio of net debt to EBITDA(e)
|
3.7 | x | 2.9 | x | 1.6 | x | ||||||||||||||||||||||
14
Selected operating data
The following table sets forth operating statistics for our specialty hospital and our outpatient rehabilitation segments for each of the periods presented and is not adjusted to reflect the Kessler Acquisition. The data in the table reflects the changes in the number of long term acute care hospitals and outpatient rehabilitation clinics we operate that resulted from acquisitions, start-up activities and closures. The operating statistics reflect data for the period of time these operations were managed by us. Further information on our acquisition activities can be found in “Management’s discussion and analysis of financial condition and results of operations—Results of operations—Select Medical” and the notes to our consolidated financial statements.
| Six months | |||||||||||||||||||||
| Year ended December 31, | ended June 30, | ||||||||||||||||||||
| (Dollars in thousands) | 2000 | 2001 | 2002 | 2002 | 2003 | ||||||||||||||||
|
Specialty hospital data:
|
|||||||||||||||||||||
|
Number of hospitals—start of period
|
44 | 54 | 64 | 64 | 72 | ||||||||||||||||
|
Number of hospital start-ups
|
10 | 10 | 8 | 2 | 4 | ||||||||||||||||
|
Number of hospitals closed
|
- | - | - | - | (1 | ) | |||||||||||||||
|
Number of hospitals—end of
period(f)
|
54 | 64 | 72 | 66 | 75 | ||||||||||||||||
|
Available licensed beds(g)
|
1,982 | 2,307 | 2,594 | 2,383 | 2,758 | ||||||||||||||||
|
Admissions(h)
|
14,210 | 17,416 | 21,065 | 10,230 | 12,075 | ||||||||||||||||
|
Patient days(i)
|
427,448 | 519,297 | 619,322 | 303,811 | 333,763 | ||||||||||||||||
|
Average length of stay(j)
|
30 | 30 | 30 | 30 | 28 | ||||||||||||||||
|
Occupancy rate(k)
|
63% | 68% | 71% | 72% | 70% | ||||||||||||||||
|
Percent patient days—Medicare(l)
|
76% | 75% | 76% | 77% | 77% | ||||||||||||||||
|
Adjusted EBITDA(d)
|
$ | 44,550 | $ | 57,556 | $ | 70,891 | $ | 32,948 | $ | 56,194 | |||||||||||
|
Outpatient rehabilitation data:
|
|||||||||||||||||||||
|
Number of clinics—start of period
|
620 | 636 | 664 | 664 | 679 | ||||||||||||||||
|
Number of clinics acquired
|
17 | 32 | 14 | 7 | 33 | ||||||||||||||||
|
Number of clinics start-ups
|
32 | 41 | 49 | 32 | 17 | ||||||||||||||||
|
Number of clinics closed/sold
|
(33 | ) | (45 | ) | (48 | ) | (17 | ) | (22 | ) | |||||||||||
|
Number of clinics owned—end of period
|
636 | 664 | 679 | 686 | 707 | ||||||||||||||||
|
Number of clinics managed—end of
period(m)
|
43 | 53 | 58 | 54 | 30 | ||||||||||||||||
|
Total number of clinics
|
679 | 717 | 737 | 740 | 737 | ||||||||||||||||
|
Adjusted EBITDA(d)
|
$ | 65,420 | $ | 76,127 | $ | 81,136 | $ | 44,123 | $ | 42,894 | |||||||||||
(a) Operating expenses include cost of services, general and administrative expenses, and bad debt expenses.
| (b) | Reflects the write-off of deferred financing costs that resulted from the refinancing of our senior credit facilities in September 2000. Also reflects the write-off of deferred financing costs and discounts resulting from the repayment of indebtedness with the proceeds from our initial public offering in April 2001 and the 9 1/2% senior subordinated notes offering in June 2001. |
| (c) | Reflects interests held by other parties in subsidiaries, limited liability companies and limited partnerships owned and controlled by us. |
| (d) | We define Adjusted EBITDA as net income before interest, income taxes, depreciation and amortization, loss on early retirement of debt, equity in (income) loss from joint ventures and minority interest. Loss on early retirement of debt, equity in (income) loss from joint ventures and minority interest are then deducted from Adjusted EBITDA to derive EBITDA. We believe that the presentation of EBITDA is important to investors because EBITDA is commonly used as an analytical indicator of performance by investors within the healthcare industry. Adjusted EBITDA as presented on a segment basis is used by management to evaluate financial performance and determine resource allocation for each of our operating segments. EBITDA and Adjusted EBITDA are not measures of financial performance under generally accepted accounting |
15
| principles. Items excluded from EBITDA and Adjusted EBITDA are significant components in understanding and assessing financial performance. EBITDA and Adjusted EBITDA should not be considered in isolation or as an alternative to, or substitute for, net income, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA and Adjusted EBITDA are not measurements determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations, EBITDA and Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies. Further information on our acquisition activities can be found in “Management’s discussion and analysis of financial condition and results of operations—Results of operations—Select Medical” and the notes to our consolidated financial statements. |
The following table reconciles EBITDA to net income:
| Six months ended | |||||||||||||||||||||||||||||
| Year ended December 31, | June 30, | ||||||||||||||||||||||||||||
| Pro forma | Pro forma | ||||||||||||||||||||||||||||
| (Dollars in thousands) | 2000 | 2001 | 2002 | 2002 | 2002 | 2003 | 2003 | ||||||||||||||||||||||
|
EBITDA
|
$ | 81,279 | $ | 94,304 | $ | 125,257 | $ | 158,542 | $ | 63,069 | $ | 80,854 | $ | 88,633 | |||||||||||||||
|
Less:
|
|||||||||||||||||||||||||||||
| Depreciation and amortization | 30,401 | 32,290 | 25,836 | 37,701 | 12,206 | 14,706 | 21,146 | ||||||||||||||||||||||
| Interest income | (939 | ) | (507 | ) | (596 | ) | (277 | ) | (207 | ) | (342 | ) | (160 | ) | |||||||||||||||
| Interest expense | 36,126 | 29,716 | 27,210 | 40,832 | 13,593 | 12,048 | 19,054 | ||||||||||||||||||||||
| Income tax expense | 9,979 | 3,124 | 28,576 | 32,431 | 14,700 | 21,357 | 19,132 | ||||||||||||||||||||||
|
Net income
|
$ | 5,712 | $ | 29,681 | $ | 44,231 | $ | 47,855 | $ | 22,777 | $ | 33,085 | $ | 29,461 | |||||||||||||||
| The SEC recently adopted rules regarding the use of non-GAAP financial measures, such as EBITDA and Adjusted EBITDA, which we use in this registration statement. Historically, we have defined EBITDA as net income (loss) before interest, income taxes, depreciation and amortization, special charges, loss on early retirement of debt and minority interest, and used this measure to report our consolidated operating results as well as our segment results. We are now referring to this financial measure as Adjusted EBITDA. In order to comply with the new rules, we are now using EBITDA, defined as net income (loss) before interest, income taxes, depreciation and amortization, to report our consolidated operating results. However, SFAS 131 requires us to report our segment results in a manner consistent with management’s internal reporting of operating results to our chief operating decision maker (as defined under SFAS 131) for purposes of evaluating segment performance. Therefore, since we use Adjusted EBITDA to measure performance of our segments for internal reporting purposes, we have used Adjusted EBITDA to report our segment results. The difference between EBITDA and Adjusted EBITDA for the periods presented in this registration statement result from loss on early retirement of debt, equity in (income) loss from joint ventures and minority interests, which are added back to EBITDA in the computation of Adjusted EBITDA. |
(e) Net debt equals total debt less cash and cash equivalents.
| (f) | As of June 30, 2003, we owned equity interests in 100% of all of our hospitals except for two hospitals that had a 14% minority owner, three hospitals that had a 3% minority owner and two hospitals that had a 9% minority owner. |
| (g) | Available licensed beds are the number of beds that are licensed with the appropriate state agency and which are readily available for patient use at the end of the period indicated. |
| (h) | Admissions represent the number of patients admitted for treatment. |
| (i) | Patient days represent the total number of days of care provided to patients. |
| (j) | Average length of stay (days) represents the average number of days patients stay in our hospitals per admission, calculated by dividing total patient days by the number of discharges for the period. |
| (k) | We calculate occupancy rate by dividing the average daily number of patients in our hospitals by the weighted average number of available licensed beds over the period indicated. |
| (l) | We calculate percent patient days—medicare by dividing the number of Medicare patient days by the total number of patient days. |
| (m) | Managed clinics are clinics that we operate through long term management arrangements and clinics operated through unconsolidated joint ventures. |
16
Risk factors
Our business involves a number of risks, some of which are beyond our control. You should carefully consider each of the risks and uncertainties we describe below and all of the other information in this prospectus before making an investment decision. The risks and uncertainties we describe below are not the only ones we face. Additional risks and uncertainties that we do not currently know or that we currently believe to be immaterial may also adversely affect our business.
Risks relating to our business
If there are changes in the rates or methods of government reimbursements for our services our net operating revenues and net income could decline.
The federal government is currently considering substantial changes to various Medicare programs. Some of these proposed changes, whether or not enacted, may affect our operations and financial results. Approximately 40.3% of our net operating revenues for the year ended December 31, 2002 came from the highly regulated federal Medicare program. The methods and rates of Medicare reimbursements may change at any time. Our long term acute care hospitals operate as Medicare-designated long term acute care hospitals. A new Medicare prospective payment system has been established and is being implemented for long term acute care hospitals under which our hospitals are paid a fixed amount for each patient based on the patient’s diagnosis. In this offering memorandum we will refer to this prospective payment system for long term acute care hospitals as “LTCH-PPS”. The new payment system is being phased in over five years during which an increasing percentage of the payment amount for each Medicare patient will be based on the fixed amount and a lesser percentage will be based on the prior reasonable cost-based system subject to caps, although facilities may elect earlier to be paid solely on the basis of the fixed amounts. As of June 30, 2003, forty-nine of our hospitals have converted to LTCH-PPS, and forty-eight of those hospitals elected to accelerate their adoption of LTCH-PPS and be paid solely on the basis of long term care diagnosis-related group payment rates, which we refer to in this offering memorandum as “LTC-DRG”. There are risks associated with transitioning to the new payment system and we are still assessing the potential impact of the LTCH-PPS. Over time, increases in LTC-DRG may not fully reflect increases in our long-term acute care hospital costs. See “Our business— Government regulations— Overview of U.S. and state government reimbursements— Long term acute care hospital Medicare reimbursement.”
Since our acquisition of Kessler, we also operate Medicare-certified inpatient rehabilitation facilities. A Medicare prospective payment system, distinct from the system applicable to long term acute care hospitals, was recently implemented for inpatient rehabilitation facilities, which is referred to as IRF-PPS. Under IRF-PPS, the Kessler hospitals are paid a fixed amount for each patient based upon the condition for which the patient is being treated. Under the IRF-PPS, each patient discharged from an inpatient rehabilitation facility is assigned to a case mix group, or “IRF-CMG,” containing patients with similar clinical problems that are expected to require similar amounts of resources. Over time, increases in IRF-CMG payment rates may not fully reflect increases in our inpatient rehabilitation facility costs. Kessler’s inpatient rehabilitation facilities began to be paid under IRF-PPS on January 1, 2002. See “—Government regulations— Overview of U.S. and state government reimbursements— Inpatient rehabilitation facility Medicare reimbursement.”
17
Our outpatient rehabilitation clinics receive payments from the Medicare program under a fee schedule. These payments are currently subject to annual caps that limit the amounts that are paid (including deductible and coinsurance amounts) for outpatient therapy services rendered to any Medicare beneficiary. Initially, the limits were to be effective January 1, 1999. Congress imposed a moratorium on the caps through 2002. The limits were then scheduled to go into effect on July 1, 2003. Following a settlement with a group of plaintiffs seeking to stop the implementation of the therapy caps, CMS delayed the application of these limits until September 1, 2003. The 2003 caps— $1,590 for physical therapy (including speech-language pathology) and $1,590 for occupational therapy— will apply during the balance of 2003 (September 1 through December 31) and, beginning in 2004, inflation-adjusted caps will apply to services provided during the entire calendar year. We believe these therapy caps could have an adverse effect on the revenue we generate from providing outpatient rehabilitation services to Medicare beneficiaries, to the extent that such patients receive services with a cost in excess of the annual caps. For the fiscal year ended December 31, 2002, we received 8.8% of our outpatient rehabilitation net operating revenues from Medicare. See “Our business— Government regulations— Overview of U.S. and state government reimbursements— Outpatient rehabilitation services Medicare reimbursement.”
Implementation of modifications to the admissions policies for Kessler’s inpatient rehabilitation facilities as required in order to achieve compliance with Medicare guidelines may result in a loss of patient volume at these hospitals and, as a result, may reduce our future net operating revenues and profitability.
As of June 30, 2003, five facilities that we acquired from Kessler were certified as Medicare inpatient rehabilitation facilities. In order to be classified as inpatient rehabilitation facilities, each Medicare provider (four of these facilities are certified as one provider) must demonstrate that, during its most recent 12-month cost reporting period, it has served an inpatient population of whom at least 75 percent required intensive rehabilitation services for one or more of ten specified conditions. Recently, the Centers for Medicare & Medicaid Services proposed changes to this classification standard which requires the provider to demonstrate that, during the most recent, consecutive and appropriate 12-month period, it has served an inpatient population of whom at least 65 percent required intensive rehabilitation services for one or more of 12 specified conditions. In the past, the classification standard has been enforced by Medicare contractors inconsistently, if at all, and the Kessler inpatient rehabilitation facilities may not have been operated in full compliance with the standard. In its recent proposed rule, the Centers for Medicare & Medicaid Services indicated that it will instruct its contractors to begin enforcing the revised classification standard in cost reporting periods beginning on or after the anticipated January 1, 2004 effective date of the final rule. In order to achieve compliance with the classification standard, as it may be amended, it may be necessary for us to implement, during cost reporting periods beginning on or after January 1, 2004, more restrictive admissions policies at the Kessler facilities for patients not falling within the specified conditions. Such policies may result in decreased patient volumes, which could have a negative effect on the financial performance of these facilities. The agency has not indicated that its enforcement efforts, which are anticipated to begin in cost reporting periods beginning on or after January 1, 2005, will be retrospective; in case they are, the selling stockholder has agreed to reimburse us for amounts required to be repaid if Kessler is found to have been non-compliant with the applicable classification standard during periods prior to the Kessler Acquisition. See “—Government regulations— Overview of U.S. and state government reimbursements— Inpatient rehabilitation facility Medicare reimbursement.”
18
If our hospitals fail to maintain their certification as long term acute care hospitals or fail to qualify as hospitals separate from their host hospitals, our profitability may decline.
As of June 30, 2003, 71 of our 75 hospitals were certified as Medicare long term acute care hospitals, and the remaining four were in the process of becoming certified as Medicare long term acute care hospitals. If our hospitals fail to meet or maintain the standards for certification as long term acute care hospitals, such as average minimum length of patient stay, they will receive payments under the prospective payment system applicable to general acute care hospitals rather than payment under the system applicable to long term acute care hospitals. Payments at rates applicable to general acute care hospitals would likely result in our hospitals receiving less Medicare reimbursement than they currently receive for their patient services. Moreover, nearly all of our hospitals are subject to additional Medicare criteria because they operate as separate hospitals located in space leased from, and located in, a general acute care hospital, known as a host hospital. This is known as a “hospital within a hospital” model. These additional criteria include limitations on services purchased from the host hospital and other requirements concerning separateness from the host hospital. If several of our hospitals were to be subject to payment as general acute care hospitals or fail to comply with the separateness requirements, our profit margins would likely decrease. See “Our business— Government regulations— Overview of U.S. and state government reimbursements— Long term acute care hospital Medicare reimbursement.”
We conduct business in a heavily regulated industry, and changes in regulations or violations of regulations may result in increased costs or sanctions that reduce our net operating revenues and profitability.
The healthcare industry is subject to extensive federal, state and local laws and regulations relating to:
| • facility and professional licensure, including certificates of need; |
| • | conduct of operations, including financial relationships among healthcare providers, Medicare fraud and abuse, and physician self-referral; |
| • addition of facilities and services; and | |
| • payment for services. |
Recently, there have been heightened coordinated civil and criminal enforcement efforts by both federal and state government agencies relating to the healthcare industry, including the specialty hospital and outpatient rehabilitation clinic businesses. The ongoing investigations relate to, among other things, various referral practices, cost reporting, billing practices, physician ownership and joint ventures involving hospitals. In the future, different interpretations or enforcement of these laws and regulations could subject our current practices to allegations of impropriety or illegality or could require us to make changes in our facilities, equipment, personnel, services and capital expenditure programs, and increase our operating expenses. If we fail to comply with these extensive laws and government regulations, we could become ineligible to receive government program reimbursement, suffer civil or criminal penalties or be required to make significant changes to our operations. In addition, we could be forced to expend considerable resources responding to an investigation or other enforcement action under these laws or regulations. See “Our business— Government regulations.”
19
Integrating Kessler into our company structure may strain our resources and prove to be difficult.
The expansion of our business and operations resulting from the Kessler Acquisition may strain our administrative, operational and financial resources and will result in our incurrence of additional indebtedness. The continued integration of Kessler into our business will require substantial time, effort, attention and dedication of management resources and may distract our management from our existing business in unpredictable ways and may take longer than anticipated. The integration process could create a number of potential challenges and adverse consequences for us, including the difficulty and expense of integrating acquired personnel into our existing business, the difficulty and expense of integrating Kessler’s billing and information systems with ours, the possible unexpected loss of key employees, customers or suppliers, a possible loss of net operating revenues or an increase in operating or other costs and the assumption of liabilities and exposure to unforeseen liabilities of Kessler. These types of challenges and uncertainties could have a material adverse effect on our business, financial condition and results of operations. We may not be able to manage the combined operations and assets effectively or realize all or any of the anticipated benefits of the Kessler Acquisition.
Future acquisitions may use significant resources, may be unsuccessful and could expose us to unforeseen liabilities.
As part of our growth strategy, we intend to pursue acquisitions of specialty hospitals and outpatient rehabilitation clinics. Acquisitions may involve significant cash expenditures, debt incurrence, additional operating losses, dilutive issuances of equity securities and expenses that could have a material adverse effect on our financial condition and results of operations. Acquisitions involve numerous risks, including:
| • the difficulty and expense of integrating acquired personnel into our business; | |
| • diversion of management’s time from existing operations; | |
| • potential loss of key employees or customers of acquired companies; and |
| • | assumption of the liabilities and exposure to unforeseen liabilities of acquired companies, including liabilities for failure to comply with healthcare regulations. |
We cannot assure you that we will succeed in obtaining financing for acquisitions at a reasonable cost, or that such financing will not contain restrictive covenants that limit our operating flexibility. We also may be unable to operate acquired hospitals and outpatient rehabilitation clinics profitably or succeed in achieving improvements in their financial performance.
Our indebtedness may limit cash flow available to invest in the ongoing needs of our business to generate future cash flow, which could prevent us from fulfilling our obligations under the notes.
We have a significant amount of indebtedness. The following chart sets forth important credit information on a pro forma basis after giving effect to the Kessler Acquisition and the offering of the old notes as of June 30, 2003, or at the beginning of the period, specified below:
| (Dollars in millions) | As of June 30, 2003 | |||
|
Total indebtedness
|
$ | 400.7 | ||
|
Total stockholders’ equity
|
326.5 | |||
20
| Six | ||||
| months ended | ||||
| June 30, 2003 | ||||
|
Ratio of earnings to fixed charges
|
2.4 | x | ||
As of June 30, 2003, we had approximately $146.7 million of availability under our senior credit facility, subject to specific requirements, including compliance with financial covenants.
Our indebtedness could have important consequences to you. For example, it could:
| • | require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, reducing the availability of our cash flow to fund working capital, capital expenditures, research and development efforts and other general corporate purposes; | |
| • | increase our vulnerability to adverse general economic or industry conditions; | |
| • | limit our flexibility in planning for, or reacting to, changes in our business or the industry in which we operate; | |
| • | prevent us from raising the funds necessary to repurchase all notes tendered to us upon the occurrence of specific changes of control in our ownership, which failure to repurchase would constitute a default under the indenture governing our notes; or | |
| • | place us at a competitive disadvantage compared to our competitors that have less indebtedness. |
See “Capitalization,” “Summary consolidated financial and other data,” “Selected consolidated financial and other data,” and “Description of other indebtedness.”
Despite our level of indebtedness, we and our subsidiaries will be able to incur more debt. This could further exacerbate the risks described above.
We and our subsidiaries may be able to incur additional indebtedness in the future. Although the indenture governing the notes contains restrictions on the incurrence of additional indebtedness, these restrictions are subject to a number of qualifications and exceptions, and the indebtedness incurred in compliance with these restrictions could be substantial. Also, these restrictions do not prevent us or our subsidiaries from incurring obligations that do not constitute indebtedness. As of June 30, 2003, we have approximately $146.7 million of availability under our senior credit facility, subject to specific requirements, including compliance with financial covenants, all of which would be senior to the new notes. In addition, as of June 30, 2003 we also have outstanding $175.0 million principal amount of our 9 1/2% senior subordinated notes and $2.3 million of other senior subordinated indebtedness which will rank equally with the new notes. To the extent new debt is added to our and our subsidiaries’ currently anticipated debt levels, the substantial leverage risks described above would increase. See “Description of notes” and “Description of other indebtedness.”
21
To service our indebtedness, we will require a significant amount of cash. Our ability to generate cash depends on many factors beyond our control, including possible changes in government reimbursement rates or methods. If we cannot generate the required cash, we may not be able to make the required payments under the new notes.
Our ability to make payments on our indebtedness, including the new notes, and to fund planned capital expenditures will depend on our ability to generate cash in the future. Our future financial results would be subject to substantial fluctuations upon a significant change in government reimbursement rates or methods. We cannot assure you that our business will generate sufficient cash flow from operations, or that future borrowings will be available to us in an amount sufficient to enable us to pay our indebtedness, including the new notes, or to fund our other liquidity needs. Our inability to pay our debts would require us to pursue one or more alternative strategies, such as selling assets, refinancing or restructuring our indebtedness or selling equity capital. However, we cannot assure you that any alternative strategies will be feasible at the time or prove adequate. Also, some alternative strategies would require the prior consent of our senior secured lenders, which we may not be able to obtain. See “Management’s discussion and analysis of financial condition and results of operations” and “Description of other indebtedness.”
Future cost containment initiatives undertaken by private third party payors may limit our future net operating revenues and profitability.
Initiatives undertaken by major insurers and managed care companies to contain healthcare costs affect the profitability of our specialty hospitals and outpatient rehabilitation clinics. These payors attempt to control healthcare costs by contracting with hospitals and other healthcare providers to obtain services on a discounted basis. We believe that this trend may continue and may limit reimbursements for healthcare services. If insurers or managed care companies from whom we receive substantial payments were to reduce the amounts they pay for services, our profit margins may decline, or we may lose patients if we choose not to renew our contracts with these insurers at lower rates.
If we fail to cultivate new or maintain established relationships with the physicians in our markets, our net operating revenues may decrease.
Our success is, in part, dependent upon the admissions and referral practices of the physicians in the communities our hospitals and our outpatient rehabilitation clinics serve, and our ability to maintain good relations with these physicians. Physicians referring patients to our hospitals and clinics are generally not our employees and, in many of the markets that we serve, most physicians have admitting privileges at other hospitals and are free to refer their patients to other providers. If we are unable to successfully cultivate and maintain strong relationships with these physicians, our hospitals’ admissions and clinics’ businesses may decrease, and our net operating revenues may decline.
Shortages in qualified nurses could increase our operating costs significantly.
Our specialty hospitals are highly dependent on nurses for patient care. The availability of qualified nurses has declined in recent years, and the salaries for nurses have risen accordingly. We cannot assure you we will be able to attract and retain qualified nurses in the future. Additionally, the cost of attracting and retaining nurses may be higher than we anticipate, and as a result, our profitability could decline.
22
Competition may limit our ability to acquire hospitals and clinics and adversely affect our growth.
We have historically faced limited competition in acquiring specialty hospitals and outpatient rehabilitation clinics, but we may face heightened competition in the future. Our competitors may acquire or seek to acquire many of the hospitals and clinics that would be suitable candidates for us. This could limit our ability to grow by acquisitions or make our cost of acquisitions higher and less profitable.
If we fail to compete effectively with other hospitals, clinics and healthcare providers, our net operating revenues and profitability may decline.
The healthcare business is highly competitive, and we compete with other hospitals, rehabilitation clinics and other healthcare providers for patients. If we are unable to compete effectively in the specialty hospital and outpatient rehabilitation businesses, our net operating revenues and profitability may decline. Many of our specialty hospitals operate in geographic areas where we compete with at least one other hospital that provides similar services. Our outpatient rehabilitation clinics face competition from a variety of local and national outpatient rehabilitation providers. Other outpatient rehabilitation clinics in markets we serve may have greater name recognition and longer operating histories than our clinics. The managers of these clinics may also have stronger relationships with physicians in their communities, which could give them a competitive advantage for patient referrals.
Significant legal actions as well as the cost and possible lack of available insurance could subject us to substantial uninsured liabilities.
In recent years, physicians, hospitals and other healthcare providers have become subject to an increasing number of legal actions alleging malpractice, product liability or related legal theories. Many of these actions involve large claims and significant defense costs. We are also subject to lawsuits under a federal whistleblower statute designed to combat fraud and abuse in the healthcare industry. These lawsuits can involve significant monetary damages and award bounties to private plaintiffs who successfully bring the suits.
We maintain professional malpractice liability insurance and general liability insurance coverage. As a result of unfavorable pricing and availability trends in the professional liability insurance market and the insurance market in general, the cost and risk sharing components of professional liability coverage has changed dramatically. Many insurance underwriters have become more selective in the insurance limits and types of coverage they will provide as a result of the September 11, 2001 terrorist attacks, rising settlement costs and the significant failures of some nationally known insurance underwriters. In some instances, insurance underwriters will no longer issue new policies in certain states that have a history of high medical malpractice awards. As a result, we experienced substantial changes in our medical and professional malpractice insurance program that we renewed on December 31, 2002. Among other things, in order to obtain malpractice insurance at a reasonable cost, we were required to assume substantial self-insured retentions for our professional liability claims. A self-insured retention is a minimum amount of liability and legal fees that we must pay for each claim. We have engaged an actuary to assist us in determining the value of the losses that may occur within this self-insured retention level. Pursuant to the requirements under our insurance agreements, we will post an additional letter of credit equal to the estimated losses that we will assume for the 2003 policy year. Because of the high retention levels, we cannot predict with certainty the actual amount of the losses we will assume and pay. To the extent that
23
Risks relating to the offering
Your right to receive payments on the new notes— like the old notes, will be junior to our existing senior indebtedness and the existing senior indebtedness of the subsidiary guarantors and possibly all of our and their future indebtedness. Further, claims of creditors of our non-guarantor subsidiaries will generally have priority with respect to the assets of those subsidiaries over your claims.
The new notes— like the old notes, and the subsidiary guarantees will be subordinated to the prior payment in full of our and the subsidiary guarantors’ respective current and future senior indebtedness to the extent set forth in the indenture. In addition, the new notes and subsidiary guarantees will rank equally with our 9 1/2% senior subordinated notes, any old notes not exchanged, and the guarantees by our subsidiaries of those notes and any other future and existing senior subordinated indebtedness. As of June 30, 2003, on a pro forma basis for the Kessler Acquisition and the sale of the old notes, we would have had approximately $50.0 million of indebtedness to which the new notes would have been subordinated and $177.3 million of indebtedness to which the new notes would have had equal priority. Because of the subordination provisions of the new notes, in the event of the bankruptcy, liquidation or dissolution of our company or any guarantor, our assets or the assets of the guarantors would be available to pay obligations under the new notes and our other senior subordinated obligations only after all payments had been made on our senior indebtedness or the senior indebtedness of our subsidiary guarantors. Sufficient assets may not remain after all these payments have been made to make any payments on the new notes and our other senior subordinated obligations, including payments of interest when due. In addition, all payments on, any old notes not exchanged, the new notes and the guarantees will be prohibited in the event of a payment default on our senior indebtedness (including borrowings under the senior credit facilities) and, for limited periods, upon the occurrence of other defaults under the senior credit facilities.
We conduct all of our business through our subsidiaries. The aggregate net operating revenues and EBITDA, as defined in the Indenture, for the six months ended June 30, 2003, on a pro forma basis for the Kessler Acquisition and the sale of the old notes, of our subsidiaries that are not guaranteeing the new notes were $105.6 million and $12.6 million, respectively, and at June 30, 2003, those subsidiaries had total assets of $120.7 million. Claims of creditors of the non-guarantor subsidiaries, including trade creditors, secured creditors and unsecured creditors, and claims of preferred stockholders (if any) of the non-guarantor subsidiaries, will generally have priority with respect to their assets and earnings over the claims of creditors of our company, including holders of the new notes, even if the obligations of the subsidiaries do not constitute senior indebtedness. See “Description of notes—Ranking” and “Description of notes—Certain covenants—Limitation on indebtedness.” See also “Description of notes—
24
The new notes— like the old notes, will not be secured by our assets nor those of our subsidiaries, and the lenders under the senior credit facility will be entitled to remedies available to a secured lender, which gives them priority over the new note holders to collect amounts due to them.
In addition to being subordinated to all of our existing and future senior indebtedness and pari passu with our 9 1/2% senior subordinated notes and any old notes not exchanged, the new notes and the subsidiary guarantees will not be secured by any of our assets. Our obligations under the senior credit facility are secured by, among other things, a first priority pledge of all of the capital stock of our wholly-owned domestic subsidiaries, mortgages upon substantially all of the real property owned by us in the U.S. and by substantially all of the assets of our company and each of our existing and subsequently acquired or organized material domestic (and, to the extent no adverse tax consequences will result, foreign) subsidiaries. If we become insolvent or are liquidated, or if payment under the senior credit facility or in respect of any other secured senior indebtedness is accelerated, the lenders under the senior credit facility or holders of other secured senior indebtedness will be entitled to exercise the remedies available to a secured lender under applicable law (in addition to any remedies that may be available under documents pertaining to the senior credit facility or the other senior debt). Upon the occurrence of any default under the senior credit facility (and even without accelerating the indebtedness under the senior credit facility), the lenders may be able to prohibit the payment of the new notes and guarantees either by limiting our ability to access our cash flow or under the subordination provisions contained in the indenture governing the new notes. In addition, we and or the subsidiary guarantors may incur additional secured senior indebtedness, the holders of which will also be entitled to the remedies available to a secured lender. See “Description of other indebtedness” and “Description of notes.”
Restrictions imposed by our senior credit facility, the indentures governing our 9 1/2% senior subordinated notes and these notes limit our ability to engage in or enter into business, operating and financing arrangements, which could prevent us from taking advantage of potentially profitable business opportunities.
The operating and financial restrictions and covenants in our debt instruments, including the senior credit facility, our 9 1/2% senior subordinated notes, any old notes not exchanged and the new notes, may affect adversely our ability to finance our future operations or capital needs or engage in other business activities that may be in our interest. For example, our senior credit facility restricts our ability to, among other things:
• incur additional debt;
• pay dividends;
• make certain investments;
• incur or permit to exist certain liens;
• enter into transactions with affiliates;
• merge, consolidate or amalgamate with another company;
• transfer or otherwise dispose of assets;
25
• redeem subordinated debt;
• incur capital expenditures; and
• incur contingent obligations.
The indenture governing our 9 1/2% senior subordinated notes includes, and the old notes and the new notes offered hereby will include similar restrictions. See “Description of notes.” Our senior credit facility also requires us to comply with certain financial covenants which become more restrictive over time. Our ability to comply with these ratios may be affected by events beyond our control. A breach of any of these covenants or our inability to comply with the required financial ratios could result in a default under our senior credit facility. In the event of any default under our senior credit facility, the lenders under our senior credit facility could elect to declare all borrowings outstanding together with accrued and unpaid interest and other fees, to be due and payable, to require us to apply all of our available cash to repay these borrowings or to prevent us from making debt service payments on these notes, any of which would be an event of default under these notes. See “Description of notes” and “Description of other indebtedness.”
We may not have the ability to raise the funds necessary to finance the change of control offer required by the indentures governing the old notes and the new notes and our 9 1/2% senior subordinated notes, which would violate the terms of any old notes not exchanged, the new notes and our 9 1/2% senior subordinated notes.
Upon the occurrence of a change of control, we will be required to offer to repurchase all of our 9 1/2% senior subordinated notes, any old notes not exchanged, and all of these new notes. We cannot assure you that there will be sufficient funds available for us to make any required repurchases of these notes, upon a change of control. In addition, our senior credit facility will prohibit us from purchasing any notes and provide that the occurrence of a change of control constitutes a default. If we do not repay all borrowings under our senior credit facility or obtain a consent of our lenders under our senior credit facility to repurchase these notes, we will be prohibited from purchasing the old notes or the new notes. Our failure to purchase tendered notes would constitute a default under the indenture governing old notes not exchanged and the new notes, which, in turn, would constitute a default under our senior credit facility. See “Description of notes—Change of control.”
A subsidiary guarantee could be voided if it constitutes a fraudulent transfer under U.S. bankruptcy laws or comparable state laws, which could result in the holders of the new notes not being able to rely on that subsidiary guarantor to satisfy claims.
Our obligations under the new notes will be guaranteed on a general unsecured senior subordinated basis by the subsidiary guarantors. Under U.S. bankruptcy law and comparable provisions of state fraudulent transfer laws, a guarantee can be voided, or claims under a guarantee may be subordinated to all other debts of that guarantor if, among other things, the guarantor, at the time it incurred the indebtedness evidenced by its guarantee:
| • | intended to hinder, delay or defraud any present or future creditor or received less than reasonably equivalent value or fair consideration for the incurrence of the guarantee; and |
26
| • | the guarantor: |
| - | was insolvent or rendered insolvent by reason of the incurrence; | |
| - | was engaged in a business or transaction for which the guarantor’s remaining assets constituted unreasonably small capital; or | |
| - | intended to incur, or believed that it would incur, debts beyond its ability to pay those debts as they mature. |
In addition, any payment by that guarantor under a guarantee could be voided and required to be returned to the guarantor or to a fund for the benefit of the creditors of the guarantor.
The measures of insolvency for purposes of fraudulent transfer laws will vary depending upon the governing law. Generally, a guarantor would be considered insolvent if:
| • | the sum of its debts, including contingent liabilities, was greater than the fair saleable value of all of its assets; | |
| • | the present fair salable value of its assets was less than the amount that would be required to pay its probable liability on its existing debts, including contingent liabilities, as they become absolute and mature; or | |
| • | it could not pay its debts as they become due. |
There is no public trading market for the new notes and an active trading market may not develop for the new notes.
The old notes are currently eligible for trading in the PORTAL Market, a screen-based market operated by the National Association of Securities Dealers. The PORTAL market is limited to qualified institutional investors as defined by Rule 144A of the Securities Act. The new notes are new securities for which there is no established trading market. We do not intend to apply for listing or quotation of the notes on any securities exchange or stock market.
J.P. Morgan Securities Inc., Merrill Lynch, Pierce, Fenner & Smith, Inc., Wachovia Capital Markets, SG Cowen, CIBC World Markets Corp., Fleet Securities, Inc. and Jefferies & Company, Inc. acted as initial purchasers in connection with the offer and sale of the old notes. The initial purchasers have informed us that they intend to make a market in the notes. However, these initial purchasers may cease their market-making at any time. In addition, the liquidity of the trading market in the new notes, and the market price quoted for the new notes, may be adversely affected by changes in the overall market for high yield securities and by changes in our financial performance or prospects or in the prospects for companies in our industry generally. As a result, we cannot assure you that an active trading market will develop for the new notes.
Failure to tender your old notes for new notes could limit your ability to resell the old notes.
The old notes were not registered under the Securities Act or under the securities laws of any state and may not be resold, offered for resale or otherwise transferred unless they are subsequently registered or resold under an exemption from the registration requirements of the Securities Act and applicable state securities laws. If you do not exchange your old notes for new notes under the exchange offer, you will not be able to resell, offer to resell or otherwise transfer the old notes unless they are registered under the Securities Act or unless you resell them, offer to resell or otherwise transfer them under an exemption from the
27
Risk relating to our structure
We have a holding company structure and will depend on distributions from our operating subsidiaries to pay these new notes. Contractual or legal restrictions applicable to our subsidiaries could limit distributions from them.
We are a holding company and derive all of our operating income from, and hold substantially all of our assets through, our subsidiaries. The effect of this structure is that we will depend on the earnings of our subsidiaries, and the payment or other distributions to us of these earnings, to meet our obligations under our senior credit facility, our 9 1/2% senior subordinated notes, any old notes not exchanged and these new notes. Provisions of law, like those requiring that dividends be paid only out of surplus, and provisions of our senior indebtedness and the indenture governing our 9 1/2% senior subordinated notes limit the ability of our subsidiaries to make payments or other distributions to us. Our subsidiaries also could agree to other contractual restrictions on their ability to make distributions. See “Description of other indebtedness.”
A substantial number of shares of our common stock are owned by a limited number of persons, and their interests may conflict with your interests.
Affiliates of Welsh, Carson, Anderson & Stowe VII, L.P., GTCR Golder Rauner, LLC, Thoma Cressey Equity Partners, and our directors and executive officers together own a substantial portion of our outstanding common stock. By virtue of this stock ownership, such persons have the power to significantly influence our affairs and are able to influence the outcome of matters required to be submitted to stockholders for approval, including the election of directors and the amendment of our certificate of incorporation or bylaws. We cannot assure you that such persons will not exercise their influence over us in a manner detrimental to your interests.
If provisions in our corporate documents and Delaware law delay or prevent a change in control of our company, we may be unable to consummate a transaction that our stockholders consider favorable.
Our certificate of incorporation, by-laws and shareholder rights plan may discourage, delay, or prevent a merger or acquisition involving us that our stockholders may consider favorable by:
| • | authorizing the issuance of preferred stock, the terms of which may be determined at the sole discretion of the board of directors; | |
| • | providing for a classified board of directors with staggered three-year terms; |
28
| • | establishing advance notice requirements for nominations for election to the board of directors or for proposing matters that can be acted on by stockholders at meetings; and | |
| • | deterring hostile takeover attempts by preventing potential acquirors from acquiring beneficial ownership of 15% or more of our common stock without our consent. |
29
Use of proceeds
We will not receive any proceeds from the exchange offer. In consideration for issuing the new notes, we will receive in exchange old notes of like principal amount, the terms of which are identical in all material respects to the new notes. The old notes surrendered in exchange for new notes will be retired and canceled and cannot be reissued. Accordingly, issuance of the new notes will not result in any increase in our indebtedness. We have agreed to bear the expenses of the exchange offer. No underwriter is being used in connection with the exchange offer.
The net proceeds from the sale of the old notes was approximately $169.4 million, after deducting initial purchaser discounts, and estimated fees and expenses of the offering. We used the net proceeds from this offering of the old notes to fund a portion of the purchase price of the Kessler Acquisition.
The following table sets forth the sources and uses of funds in connection with the closing of the Kessler Acquisition:
| Sources of funds: | (Dollars in thousands) | ||||
|
7 1/2% senior subordinated notes due 2013
|
$ | 175,000 | |||
|
Existing cash
|
64,027 | ||||
|
Total sources
|
$ | 239,027 | |||
| Uses of funds: | (Dollars in thousands) | ||||
|
Kessler cash purchase price(a)
|
$ | 228,318 | |||
|
Acquisition costs paid at closing
|
5,109 | ||||
|
Financing and related fees
|
5,600 | ||||
|
Total uses
|
$ | 239,027 | |||
| (a) | The purchase price is subject to a post-closing adjustment based upon the amount of working capital at closing. In addition, we have accrued $11.5 million for transaction related costs that are expected to be funded post-closing. |
30
Capitalization
The following table sets forth (i) our capitalization as of June 30, 2003 on an actual basis and (ii) our capitalization on a pro forma basis to give effect to the Kessler Acquisition and the sale of the old notes as if these transactions had been completed on June 30, 2003.
| As of June 30, 2003 | |||||||||
| (Dollars in thousands) | Actual | Pro forma | |||||||
|
Cash and cash equivalents
|
$ | 91,351 | $ | 26,471 | (a) | ||||
|
Revolving credit facility
|
- | (b) | - | (a) | |||||
|
Existing term loans
|
39,919 | 39,919 | |||||||
|
Other senior debt
|
2,651 | 4,404 | (c) | ||||||
|
Total senior debt
|
42,570 | 44,323 | |||||||
|
9 1/2% senior subordinated notes due 2009
|
175,000 | 175,000 | |||||||
|
7 1/2% senior subordinated notes due 2013
|
- | 175,000 | |||||||
|
Other debt
|
6,373 | 6,373 | |||||||
|
Total debt
|
223,943 | 400,696 | |||||||
|
Total stockholders’ equity
|
326,539 | 326,539 | |||||||
|
Total capitalization
|
$ | 550,482 | $ | 727,235 | |||||
| (a) | The unaudited pro forma capitalization information above is presented on a pro forma basis to give effect to the Kessler Acquisition and the offering of the old notes as if these transactions had been completed on June 30, 2003, consistent with the information presented in “Unaudited pro forma combined financial information.” |
(b) As of June 30, 2003, we had $146.7 million of availability under our revolving credit facility, subject to certain limitations.
| (c) | Includes approximately $1.7 million of debt, issued by Kessler in connection with past acquisitions. |
31
Unaudited pro forma combined financial information
Our historical consolidated financial statements and the historical financial statements of Kessler Rehabilitation Corporation are included elsewhere in this prospectus. The unaudited pro forma combined financial information presented herein should be read together with those financial statements and related notes and “Management’s discussion and analysis of financial condition and results of operations.”
We prepared the unaudited pro forma combined financial information to reflect:
| • | The acquisition of Kessler Rehabilitation Corporation; and |
| • | The sale of the old notes described in this prospectus |
as if such events had occurred on January 1, 2002 and January 1, 2003 for the pro forma combined statements of operations for the year ended December 31, 2002, and the six months ended June 30, 2003, respectively. We prepared the pro forma combined balance sheet as if the events had occurred on June 30, 2003.
We adjusted our historical consolidated statements of operations for the year ended December 31, 2002 and the six months ended June 30, 2003 to arrive at the unaudited pro forma combined statements of operations for the year ended December 31, 2002 and the six months ended June 30, 2003.
No adjustments have been made with respect to a number of small acquisitions made during 2002 and 2003 since these acquisitions are not material to the pro forma results.
The acquisition of Kessler Rehabilitation Corporation for $228.3 million in cash, the assumption of $1.7 million of indebtedness and estimated acquisition and reorganization costs of $16.6 million has been accounted for using the purchase method of accounting. Actual acquisition costs may differ from this estimate based upon our final integration plans. The purchase price was allocated to the fair value of Kessler Rehabilitation Corporation’s assets and liabilities based on preliminary valuation estimates. The excess purchase price was allocated to goodwill. Under generally accepted accounting principles, goodwill is not amortized but is reviewed for impairment annually. A formal valuation study is currently being performed to identify and value all tangible and identifiable intangible assets. Thus, the actual acquisition costs and the allocation of these costs may differ from these pro forma financial statements. If our non-goodwill assets are written up to a higher fair value in connection with the valuation study, our expenses in the future will be higher as a result of increased depreciation or amortization of our assets.
Certain information normally included in financial statements prepared in accordance with generally accepted accounting principles has been omitted pursuant to the rules and regulations of the Securities and Exchange Commission.
The pro forma combined statements of operations are not necessarily indicative of results that would have occurred had the acquisition been completed on January 1, 2002 and January 1, 2003 and should not be construed as being representative of future results of operations.
32
Unaudited pro forma combined balance sheet
| As of June 30, 2003 | |||||||||||||||||
| Select | Kessler | ||||||||||||||||
| (Dollars in thousands) | historical | historical | Adjustments | Pro forma | |||||||||||||
|
Current assets:
|
|||||||||||||||||
|
Cash and cash equivalents
|
$ | 91,351 | $ | 20,537 | $ | (85,417 | ) (a)(b)(g) | $ | 26,471 | ||||||||
|
Accounts receivable, net
|
199,723 | 45,003 | - | 244,726 | |||||||||||||
|
Current deferred tax asset
|
42,058 | 14,005 | (413 | )(b) | 55,650 | ||||||||||||
|
Other current assets
|
17,265 | 4,595 | - | 21,860 | |||||||||||||
|
Total current assets
|
350,397 | 84,140 | (85,830 | ) | 348,707 | ||||||||||||
|
Property and equipment, net
|
112,421 | 59,334 | 5,269 | (i) | 177,024 | ||||||||||||
|
Goodwill
|
211,348 | 23,005 | 83,639 | (c) | 317,992 | ||||||||||||
|
Trademark
|
37,875 | - | - | 37,875 | |||||||||||||
|
Intangible assets
|
935 | - | 23,956 | (j) | 24,891 | ||||||||||||
|
Prepaid pension expense
|
- | 15,526 | (15,526 | ) (d) | - | ||||||||||||
|
Non-current deferred tax asset
|
7,262 | 2,100 | 5,795 | (d)(e)(f) | 15,157 | ||||||||||||
|
Other assets
|
17,622 | 4,581 | 5,013 | (e)(f)(g) | 27,216 | ||||||||||||
|
Total assets
|
$ | 737,860 | $ | 188,686 | $ | 22,316 | $ | 948,862 | |||||||||
|
Current liabilities:
|
|||||||||||||||||
|
Bank overdrafts
|
$ | 6,765 | $ | - | $ | - | $ | 6,765 | |||||||||
|
Current portion of long-term debt and notes
payable
|
22,176 | 3,795 | (2,750 | ) (f) | 23,221 | ||||||||||||
|
Accounts payable and accrued expenses
|
135,031 | 22,811 | 10,479 | (b)(h) | 168,321 | ||||||||||||
|
Income taxes payable
|
8,917 | 1,109 | (3,921 | ) (b)(e)(k) | 6,105 | ||||||||||||
|
Due to third party payors
|
31,438 | 3,771 | - | 35,209 | |||||||||||||
|
Total current liabilities
|
204,327 | 31,486 | 3,808 | 239,621 | |||||||||||||
|
Long-term debt, net of current portion
|
201,767 | 35,458 | 140,250 | (f)(g) | 377,475 | ||||||||||||
|
Other long-term liabilities
|
- | 1,260 | (1,260 | ) (b)(f) | - | ||||||||||||
|
Total liabilities
|
406,094 | 68,204 | 142,798 | 617,096 | |||||||||||||
|
Minority interest in consolidated subsidiary
companies
|
5,227 | - | - | 5,227 | |||||||||||||
|
Stockholders’ equity:
|
|||||||||||||||||
|
Common stock
|
481 | 2 | (2 | )(l) | 481 | ||||||||||||
|
Capital in excess of par
|
238,685 | 114,430 | (114,430 | ) (l) | 238,685 | ||||||||||||
|
Retained earnings
|
83,240 | 6,815 | (6,815 | ) (l) | 83,240 | ||||||||||||
|
Accumulated other comprehensive income (loss)
|
4,133 | (765 | ) | 765 | (l) | 4,133 | |||||||||||
|
Total stockholders’ equity
|
326,539 | 120,482 | (120,482 | ) | 326,539 | ||||||||||||
|
Total liabilities and stockholders’
equity
|
$ | 737,860 | $ | 188,686 | $ | 22,316 | $ | 948,862 | |||||||||
33
Unaudited pro forma combined statement of operations
| Six months ended June 30, 2003 | ||||||||||||||||
| Select | Kessler | |||||||||||||||
| (Dollars in thousands except per share data) | historical | historical | Adjustments | Pro forma | ||||||||||||
|
Net operating revenues
|
$ | 638,525 | $ | 118,632 | $ | - | $ | 757,157 | ||||||||
|
Operating expenses
|
556,134 | 111,013 | - | 667,147 | ||||||||||||
|
Depreciation and amortization
|
14,706 | 4,729 | 1,711 | (j) | 21,146 | |||||||||||
|
Total costs and expenses
|
570,840 | 115,742 | 1,711 | 688,293 | ||||||||||||
|
Income from operations
|
67,685 | 2,890 | (1,711 | ) | 68,864 | |||||||||||
|
Equity in income from joint ventures
|
- | (8 | ) | (152 | )(e) | (160 | ) | |||||||||
|
Interest expense, net
|
11,706 | 1,265 | 5,923 | (f)(g) | 18,894 | |||||||||||
|
Income before minority interests and income tax
expense
|
55,979 | 1,633 | (7,482 | ) | 50,130 | |||||||||||
|
Minority interests
|
1,537 | - | - | 1,537 | ||||||||||||
|
Income before income taxes
|
54,442 | 1,633 | (7,482 | ) | 48,593 | |||||||||||
|
Income tax expense
|
21,357 | 677 | (2,902 | ) (m) | 19,132 | |||||||||||
|
Net income
|
$ | 33,085 | $ | 956 | $ | (4,580 | ) | $ | 29,461 | |||||||
|
Basic income per common share
|
$ | 0.70 | $ | 0.62 | ||||||||||||
|
Weighed average basic common shares outstanding
(in thousands)
|
47,339 | 47,339 | ||||||||||||||
|
Diluted income per common share
|
$ | 0.66 | $ | 0.59 | ||||||||||||
|
Weighted average diluted common shares
outstanding (in thousands)
|
50,002 | 50,002 | ||||||||||||||
34
Unaudited pro forma combined statement of operations
| Year ended December 31, 2002 | ||||||||||||||||
| Select | Kessler | |||||||||||||||
| (Dollars in thousands except per share data) | historical | historical | Adjustments | Pro forma | ||||||||||||
|
Net operating revenues
|
$ | 1,126,559 | $ | 227,635 | $ | - | $ | 1,354,194 | ||||||||
|
Operating expenses
|
999,280 | 193,461 | - | 1,192,741 | ||||||||||||
|
Depreciation and amortization
|
25,836 | 8,443 | 3,422(j | ) | 37,701 | |||||||||||
|
Total costs and expenses
|
1,025,116 | 201,904 | 3,422 | 1,230,442 | ||||||||||||
|
Income from operations
|
101,443 | 25,731 | (3,422 | ) | 123,752 | |||||||||||
|
Equity in losses from joint ventures
|
- | 1,636 | (747 | )(e) | 889 | |||||||||||
|
Interest expense, net
|
26,614 | 2,181 | 11,760 | (f)(g) | 40,555 | |||||||||||
|
Income before minority interests, income tax
expense and cumulative effect of accounting change
|
74,829 | 21,914 | (14,435 | ) | 82,308 | |||||||||||
|
Minority interests
|
2,022 | - | - | 2,022 | ||||||||||||
|
Income before income taxes and cumulative effect
of accounting change
|
72,807 | 21,914 | (14,435 | ) | 80,286 | |||||||||||
|
Income tax expense
|
28,576 | 9,401 | (5,546 | )(m) | 32,431 | |||||||||||
|
Income before cumulative effect of accounting
change
|
$ | 44,231 | $ | 12,513 | $ | (8,889 | ) | $ | 47,855 | |||||||
|
Basic income per common share
|
$ | 0.95 | $ | 1.03 | ||||||||||||
|
Weighted average basic common shares outstanding
(in thousands)
|
46,464 | 46,464 | ||||||||||||||
|
Diluted income per common share
|
$ | 0.90 | $ | 0.97 | ||||||||||||
|
Weighted average diluted common shares
outstanding (in thousands)
|
49,128 | 49,128 | ||||||||||||||
35
Notes to unaudited pro forma combined
The following adjustments were applied to our consolidated statements of operations and consolidated balance sheet and the financial statements of Kessler Rehabilitation Corporation.
| (a) | The elimination of $19.9 million of cash being held by Kessler Rehabilitation Corporation at June 30, 2003, that exceeded the target working capital of $34.4 million as specified by the stock purchase agreement. This excess cash was distributed to the selling stockholder prior to closing. |